Unnamed: 0,title,date,stock,sentiment
1031480.0,"New York Attorney General: Complaint Alleges Taro, Perrigo, Fougera Repeatedly Communicated Directly, Specifically To Minimize Competition",2020-06-10 11:10:00-04:00,PRGO,negative
1031481.0,10 Biggest Price Target Changes For Monday,2020-06-08 08:35:00-04:00,PRGO,neutral
1031482.0,"SVB Leerink Maintains Outperform on Perrigo, Raises Price Target to $63",2020-06-08 06:34:00-04:00,PRGO,neutral
1031483.0,"In The Midst Of Pandemic, Traders Pin Their Hopes On These Healthcare ETFs",2020-05-19 09:38:00-04:00,PRGO,positive
1031484.0,Perrigo shares are trading lower after the company reported Q1 results.,2020-04-30 09:10:00-04:00,PRGO,neutral
1031485.0,"Perrigo Co Q1 Adj. EPS $1.140 Beats $1.030 Estimate, Sales $1.341B Beat $1.310B Estimate",2020-04-30 06:32:00-04:00,PRGO,neutral
1031486.0,"Earnings Scheduled For April 30, 2020",2020-04-30 04:16:00-04:00,PRGO,neutral
1031487.0,Argus Research Downgrades Perrigo to Hold,2020-04-17 11:38:00-04:00,PRGO,neutral
1031488.0,Shares of several healthcare companies are trading higher amid overall market strength after the US Federal Reserve announced a further $2.3 trillion in financing programs to support the economy. Other potential positive sector catalysts include demand for therapies and medical supplies amid the coronavirus pandemic and US Senator Sanders exiting the Presidential race.,2020-04-09 09:58:00-04:00,PRGO,positive
1031489.0,"Perrigo Reports Prelim. Q1 Sales ~$1.3B vs $1.26B Estimate, Adj. Operating Income $220M-$225M",2020-04-07 16:52:00-04:00,PRGO,neutral
1031490.0,Perrigo Reports FDA Approval For Store-Brand Equivalent Of Voltaren Arthritis Pain,2020-04-06 08:30:00-04:00,PRGO,negative
1031491.0,Perrigo shares are trading lower despite rebound in equities. Morgan Stanley lowered its price target on the company's stock from $54 to $53.,2020-04-02 11:38:00-04:00,PRGO,negative
1031492.0,"Morgan Stanley Maintains Equal-Weight on Perrigo, Lowers Price Target to $53",2020-04-02 09:24:00-04:00,PRGO,negative
1031493.0,"JP Morgan Upgrades Perrigo to Overweight, Announces $57 Price Target",2020-03-24 05:05:00-04:00,PRGO,neutral
1031494.0,"Benzinga's Top Upgrades, Downgrades For March 20, 2020",2020-03-20 10:15:00-04:00,PRGO,positive
1031495.0,"SVB Leerink Upgrades Perrigo to Outperform, Lowers Price Target to $52",2020-03-20 08:57:00-04:00,PRGO,negative
1031496.0,Shares of several companies in the healthcare space are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy.,2020-03-16 10:18:00-04:00,PRGO,negative
1031497.0,"Wells Fargo Maintains Equal-Weight on Perrigo, Lowers Price Target to $53",2020-03-11 08:09:00-04:00,PRGO,positive
1031498.0,Shares of several healthcare  companies are trading lower. Movement appears market-related as markets continue to dip amid the global coronavirus outbreak and OPEC failing to reach production agreement.,2020-03-09 10:55:00-04:00,PRGO,neutral
1031499.0,Shares of several healthcare companies are trading lower. Movement appears market related as markets continue to dip amid the global coronavirus outbreak.,2020-03-06 09:11:00-05:00,PRGO,neutral
1031500.0,Shares of several healthcare companies are trading lower as the global coronavirus spread continues to cause equities across sectors to sell off amid worsened economic outlook.,2020-02-28 09:06:00-05:00,PRGO,negative
1031501.0,140 Biggest Movers From Yesterday,2020-02-28 05:00:00-05:00,PRGO,neutral
1031502.0,100 Stocks Moving In Thursday's Mid-Day Session,2020-02-27 12:24:00-05:00,PRGO,neutral
1031503.0,Shares of several healthcare companies are trading lower as growing coronavirus fears hamper economic outlook.,2020-02-27 09:28:00-05:00,PRGO,negative
1031504.0,40 Stocks Moving in Thursday's Pre-Market Session,2020-02-27 07:13:00-05:00,PRGO,neutral
1031505.0,"Perrigo Co Q4 Adj. EPS $1.06, Sales $1.3B, Both Inline",2020-02-27 06:33:00-05:00,PRGO,neutral
1031506.0,"Earnings Scheduled For February 27, 2020",2020-02-27 04:51:00-05:00,PRGO,neutral
1031507.0,Q4 Earnings Preview For Perrigo Co,2020-02-26 13:12:00-05:00,PRGO,neutral
1031508.0,55 Stocks Moving In Tuesday's Mid-Day Session,2020-02-25 12:24:00-05:00,PRGO,neutral
1031509.0,Stocks That Hit 52-Week Highs On Tuesday,2020-02-25 10:15:00-05:00,PRGO,neutral
1031510.0,22 Stocks Moving in Tuesday's Pre-Market Session,2020-02-25 07:44:00-05:00,PRGO,neutral
1031511.0,Perrigo shares are trading higher after the company announced it has received FDA approval for its AB-rated generic version of ProAir HFA.,2020-02-25 07:37:00-05:00,PRGO,positive
1031512.0,"A Peek Into The Markets: US Stock Futures Up Ahead Of Home-Price, Consumer Confidence Data",2020-02-25 06:13:00-05:00,PRGO,positive
1031513.0,"Perrigo, Catalent Announce FDA Approval of Perrigo's AB-rated Generic Version of ProAir HFA",2020-02-25 05:26:00-05:00,PRGO,positive
1031514.0,Perrigo To Purchase Oral Care Assets Of High Ridge Brands For $113M In Cash,2020-02-24 08:59:00-05:00,PRGO,positive
1031515.0,Perrigo Raises Qtr. Dividend From $0.21 To $0.225/Share,2020-02-18 10:19:00-05:00,PRGO,neutral
1031516.0,"Opiant Pharmaceuticals Inc On February 12, 2020, Plaintiffs And Perrigo Entered Into A Settlement Agreement To Resolve Certain Ongoing Litigation",2020-02-18 08:53:00-05:00,PRGO,positive
1031517.0,Starboard Value 13F Shows Dissolved Stake In Perrigo,2020-02-14 16:26:00-05:00,PRGO,positive
1031518.0,Stocks That Hit 52-Week Highs On Monday,2020-02-10 10:25:00-05:00,PRGO,neutral
1031519.0,Stocks That Hit 52-Week Highs On Wednesday,2020-01-22 10:17:00-05:00,PRGO,neutral
1031520.0,"Cantor Fitzgerald Maintains Overweight on Perrigo Co, Raises Price Target to $70",2020-01-21 08:17:00-05:00,PRGO,negative
1031521.0,Stocks That Hit 52-Week Highs On Friday,2020-01-17 13:23:00-05:00,PRGO,neutral
1031522.0,Stocks That Hit 52-Week Highs On Wednesday,2020-01-15 13:14:00-05:00,PRGO,neutral
1031523.0,80 Biggest Movers From Yesterday,2020-01-15 04:48:00-05:00,PRGO,neutral
1031524.0,Perrigo shares are trading higher after the company also announced strong preliminary Q4 net sales.,2020-01-14 10:45:00-05:00,PRGO,positive
1031525.0,8 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-11-27 07:30:00-05:00,PRGO,neutral
1031526.0,"Q3 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios",2019-11-15 12:29:00-05:00,PRGO,neutral
1031527.0,Starboard 13F Shows Raised Stake In Perrigo From 4.1M Shares To ~10M Shares,2019-11-14 16:09:00-05:00,PRGO,positive
1031528.0,"The Week In Cannabis: Drake And Tony Hawk Get In The Weeds, Linton Joins Vireo, And A Myriad Of Earnings",2019-11-08 17:10:00-05:00,PRGO,neutral
1031529.0,"Witi, Perrigo Partner To Help Smokers Overcome Nicotine Addiction",2019-11-07 13:09:00-05:00,PRGO,positive
1031530.0,Perrigo Co PLC shares are trading lower after the company reported worse-than-expected Q3 sales results.,2019-11-06 11:35:00-05:00,PRGO,neutral
1031531.0,Perrigo Raises FY19 Adj. EPS Guidance From $3.75-$4.05 To $3.85-$4.05 vs $3.93 Est.,2019-11-06 06:05:00-05:00,PRGO,neutral
1031532.0,"Perrigo Co Q3 Adj. EPS $1.04 Beats $0.93 Estimate, Sales $1.191B Miss $1.2B Estimate",2019-11-06 06:04:00-05:00,PRGO,negative
1031533.0,"Earnings Scheduled For November 6, 2019",2019-11-06 04:13:00-05:00,PRGO,neutral
1031534.0,"Perrigo Company Issues Voluntary Worldwide Recall Of Ranitidine Due To Possible Presence Of Impurity, N-nitrosodimethylamine (NDMA) Impurity In The product",2019-10-23 16:07:00-04:00,PRGO,neutral
1031535.0,"Benzinga's Top Upgrades, Downgrades For October 11, 2019",2019-10-11 10:10:00-04:00,PRGO,positive
1031536.0,Argus Research Upgrades Perrigo Co to Buy,2019-10-11 07:48:00-04:00,PRGO,neutral
1031537.0,Perrigo Highlights Relaunch Of AB-Rated Generic Version Of Transderm Scop 1.5 MG,2019-10-03 08:18:00-04:00,PRGO,neutral
1031538.0,"Wells Fargo Maintains Market Perform on Perrigo Co, Raises Price Target to $52",2019-09-30 08:03:00-04:00,PRGO,positive
1031539.0,"Biotech Stock On The Radar: Anavex, A Neurology-Focused Precision Medicine Company",2019-09-25 17:32:00-04:00,PRGO,neutral
1031540.0,"SunTrust Robinson Humphrey Maintains Hold on Perrigo Co, Raises Price Target to $55",2019-09-25 09:25:00-04:00,PRGO,neutral
1031541.0,Shares of several drug companies are trading higher after Senate Majority Leader McConnell suggested a new Democratic drug price reform proposal would be dead on arrival.,2019-09-20 13:00:00-04:00,PRGO,negative
1031542.0,"Perrigo Reports Purchase Of Prevacid 24hr, No Terms Disclosed",2019-09-05 08:37:00-04:00,PRGO,negative
1031543.0,Perrigo Settled Hatch-Waxman Litigation Relating To Nascobal (Cyanocobalamin) Nasal Spray Brought By Endo Pharmaceutical,2019-08-21 08:44:00-04:00,PRGO,negative
1031544.0,32 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-08-14 08:50:00-04:00,PRGO,neutral
1031545.0,ï»¿Shares of several healthcare companies are trading higher with the overall market after the U.S. announced it is excluding and delaying the additional 10% tariff on certain products.,2019-08-13 11:53:00-04:00,PRGO,positive
1031546.0,PetIQ CEO: Q2 Boosted By Sales To 'Pet Parents',2019-08-09 13:58:00-04:00,PRGO,positive
1031547.0,Perrigo Co shares are trading lower after the company reported worse-than-expected Q2 sales results.,2019-08-08 10:12:00-04:00,PRGO,neutral
1031548.0,25 Healthcare Stocks Moving In Today's Pre-Market Session,2019-08-08 08:35:00-04:00,PRGO,neutral
1031549.0,"Perrigo Reports Q2 Earnings, Reaffirms Guidance",2019-08-08 07:26:00-04:00,PRGO,neutral
1031550.0,Perrigo Reaffirms FY19 Adj. EPS $3.75-$4.05 vs $3.93 Estimate,2019-08-08 06:32:00-04:00,PRGO,neutral
1031551.0,"Perrigo Co Q2 Adj. EPS $0.86 Beats $0.79 Estimate, Sales $1.127B Miss $1.13B Estimate",2019-08-08 06:31:00-04:00,PRGO,negative
1031552.0,"Earnings Scheduled For August 8, 2019",2019-08-08 04:05:00-04:00,PRGO,neutral
1031553.0,Q2 Earnings Preview For Perrigo,2019-08-07 14:36:00-04:00,PRGO,neutral
1031554.0,28 Healthcare Stocks Moving In Today's Pre-Market Session,2019-08-06 08:55:00-04:00,PRGO,neutral
1031555.0,"Perrigo Reports FDA Final Approval, Launch Of AB-Rated Generic Version Of Metrogel-Vaginal Gel",2019-07-03 08:38:00-04:00,PRGO,positive
1031556.0,Perrigo Adjusts Guidance After Acquiring Ranir Global For $750M,2019-07-02 13:19:00-04:00,PRGO,neutral
1031557.0,Perrigo Sees Prelim. FY19 Adj. EPS $3.75 - $4.05 Including Accretion Of $0.10 From Ranir Acquisition,2019-07-02 08:56:00-04:00,PRGO,neutral
1031558.0,Shares of multiple drugmakers and biotech companies are trading higher after AbbVie announced it will acquire Allergan.,2019-06-25 11:21:00-04:00,PRGO,positive
1031559.0,Shares of several healthcare companies are trading higher with the overall US market. Recent comments out of China and Mexico has renewed trade optimism and lifted economic outlook.,2019-06-04 13:07:00-04:00,PRGO,positive
1031560.0,Shares of many healthcare companies are trading lower following a tweet from President Trump late Thursday stating the US will impose a 5 percent tariff on goods from Mexico.,2019-05-31 10:25:00-04:00,PRGO,negative
1031561.0,Sol-Gel Technologies Announces Seventh Collaborative Agreement For Generic Product Candidates With Perrigo,2019-05-28 09:01:00-04:00,PRGO,positive
1031562.0,Perrigo Reports FDA Final Approval For AB-Rated Generic Version Of Voltaren Gel 1%,2019-05-21 09:16:00-04:00,PRGO,positive
1031563.0,Perrigo Company plc Ordinary Shares Sees FY2019 EPS $3.65-3.95 vs $4.2 Est; Sees Sales $4.6B-4.7B vs $4.71B Est,2019-05-09 08:00:00-04:00,PRGO,positive
1031564.0,Perrigo Acquires Ranir Global For $750M  Private Label Oral Care Company,2019-05-09 07:53:00-04:00,PRGO,positive
1031565.0,Perrigo Highlights Steps For Self-Care Transformation Plan,2019-05-09 07:39:00-04:00,PRGO,neutral
1031566.0,"Perrigo Sees FY19 Adj EPS $3.65-$3.95 vs $4.20 Estimate, Sales $4.6B-$4.7B vs $4.71B Est.",2019-05-09 07:38:00-04:00,PRGO,neutral
1031567.0,Perrigo Reports Purchase Of Ranir Global For $750M,2019-05-09 07:26:00-04:00,PRGO,neutral
1031568.0,"Perrigo Q1 Adj. EPS $1.07 Beats $0.94 Estimate, Sales $1.175B Beat $1.15B Estimate",2019-05-08 17:08:00-04:00,PRGO,neutral
1031569.0,PetIQ to Acquire Perrigo's Animal Health Business for $185M Cash,2019-05-08 16:07:00-04:00,PRGO,neutral
1031570.0,"10 Stocks To Watch For May 8, 2019",2019-05-08 05:05:00-04:00,PRGO,neutral
1031571.0,"Earnings Scheduled For May 8, 2019",2019-05-08 04:39:00-04:00,PRGO,neutral
1031572.0,68 Biggest Movers From Yesterday,2019-05-01 06:01:00-04:00,PRGO,neutral
1031573.0,50 Stocks Moving In Tuesday's Mid-Day Session,2019-04-30 12:26:00-04:00,PRGO,neutral
1031574.0,Perrigo PLC shares are trading lower after the IRS claimed the company owes $843 million in taxes with a 40% penalty from its acquisition of Elan in December of 2013.,2019-04-30 10:48:00-04:00,PRGO,negative
1031575.0,30 Stocks Moving In Tuesday's Pre-Market Session,2019-04-30 08:08:00-04:00,PRGO,neutral
1031576.0,"Perrigo Shares Fall 7% Premarket; Co Announced Monday it Received Revised Notice Of Proposed Adjustment From IRS Examination Team Auditing Athena Neurosciences For Tax Years Ending Dec 31, 2011 - 2013",2019-04-30 04:05:00-04:00,PRGO,positive
1031577.0,Perrigo Raises Quarterly Dividend From $0.19 To $0.21/Share,2019-04-26 09:04:00-04:00,PRGO,neutral
1031578.0,"Carlyle, Altaris And Cerberus Also Said To Bid For Perrigo Unit; Perrigo Pharma Unit Is Said To Be Worth Just Over $2.5B",2019-04-04 11:30:00-04:00,PRGO,positive
1031579.0,Hearing Apollo And CVC To Vie For Perrigo Arm,2019-04-04 11:28:00-04:00,PRGO,neutral
1031580.0,"Perrigo Reports Received Tentative FDA Approval For Generic Version Of Sernivo Spray, 0.05%",2019-04-04 08:09:00-04:00,PRGO,positive
1031581.0,"Perrigo Reports Patent Litigation Settlement For Generic Version Of Finacea Foam, 15%, Terms Confidential",2019-04-02 08:01:00-04:00,PRGO,negative
1031582.0,"UPDATE: Perrigo Says Previous CFO, Ronald Winowiecki, Resigned",2019-03-20 16:31:00-04:00,PRGO,negative
1031583.0,Perrigo Names Ray Silcock CFO,2019-03-20 16:30:00-04:00,PRGO,neutral
1031584.0,"SunTrust Robinson Humphrey Initiates Coverage On Perrigo Co with Hold Rating, Announces $51 Price Target",2019-03-20 07:14:00-04:00,PRGO,neutral
1031585.0,"Perrigo Announces Tentative FDA Approval For The Generic Version Of Finacea Foam, 15%",2019-03-18 16:31:00-04:00,PRGO,positive
1031586.0,Perrigo Confirms Endo Pharma Initiated Patent Litigation Related To Co.'s Paragraph IV Abbreviated New Drug Application For Cyancobalamin Nasal Spray 500mcg,2019-03-05 08:57:00-05:00,PRGO,negative
1031587.0,34 Stocks Moving In Thursday's Pre-Market Session,2019-02-28 08:26:00-05:00,PRGO,neutral
1031588.0,10 Stocks Moving In Wednesday's After-Hours Session,2019-02-27 17:16:00-05:00,PRGO,neutral
1031589.0,Perrigo Co shares are trading lower after the company missed Q4 EPS estimates.,2019-02-27 16:30:00-05:00,PRGO,negative
1031590.0,"Perrigo Q4 Adj. EPS $0.97 Misses $1 Estimate, Sales $1.195B Beat $1.18B Estimate",2019-02-27 16:02:00-05:00,PRGO,negative
1031591.0,"Earnings Scheduled For February 27, 2019",2019-02-27 04:03:00-05:00,PRGO,neutral
1031592.0,"13F From David Einhorn's Greenlight Capital Shows New 200K Share Stake In Chemours, Liquidated Stakes In Altaba, Sherwin-Williams, Perrigo, Tractor Supply",2019-02-14 16:48:00-05:00,PRGO,positive
1031593.0,Perrigo Announces Patent Litigation Settlement For Generic Version Of Jublia Topical Solution 10%,2019-02-13 09:23:00-05:00,PRGO,positive
1031594.0,Perrigo Reports FDA Approval Of AB-Rated Generic Version Of Zovirax Cream 5%,2019-02-06 08:45:00-05:00,PRGO,positive
1031595.0,Perrigo To Receive Milestone Payment Of $250 Million From RPI Finance Trust,2019-01-29 08:24:00-05:00,PRGO,positive
1031596.0,"David Einhorn Says His Greenlight Capital Sold Mylan, Perrigo And Bayer Last Year, Covered Shorts On Core Laboratories, Oil Frackers",2019-01-23 09:51:00-05:00,PRGO,neutral
1031597.0,Dr Reddy's Evaluating $1B+ Buyout Of Prescription Generics Business Of Perrigo,2019-01-22 03:55:00-05:00,PRGO,neutral
1031598.0,Perrigo Appoints James Dillard To Chief Scientific Officer,2019-01-14 09:15:00-05:00,PRGO,neutral
1031599.0,Recent Spike Higher In Perrigo Being Attributed To Report Co. Weighing Shelving Its Irish Expansion Amid Tax Battle,2019-01-11 12:45:00-05:00,PRGO,negative
1031600.0,Perrigo Co Option Alert: Mar 15 $50 Calls at the Bid: 2541 @ $1.15 vs 219 OI; Earnings 2/28 After Close [est] Ref=$44.69,2019-01-11 12:15:00-05:00,PRGO,positive
1031601.0,"Perrigo Shares Spike ~1.9% On Volume Spike; Shares Rebounded From $44 Support/Resistance Level; Not Immediately Seeing News To Justify Price, Volume Spike",2019-01-11 12:15:00-05:00,PRGO,positive
1031602.0,Perrigo Shares Rebound From Low As Traders Circulate Speculation From Dealreporter Suggesting Co. Favors The Sale Of Its Prescription Unit Over A Spinoff,2019-01-09 10:40:00-05:00,PRGO,positive
1031603.0,20 Stocks Moving In Wednesday's Pre-Market Session,2018-12-26 07:51:00-05:00,PRGO,neutral
1031604.0,5 Biggest Price Target Changes For Monday,2018-12-24 10:09:00-05:00,PRGO,neutral
1031605.0,60 Biggest Movers From Friday,2018-12-24 04:35:00-05:00,PRGO,neutral
1031606.0,Mid-Afternoon Market Update: Dow Down Over 200 Points; TRACON Pharmaceuticals Shares Slide,2018-12-21 14:40:00-05:00,PRGO,positive
1031607.0,40 Stocks Moving In Friday's Mid-Day Session,2018-12-21 12:40:00-05:00,PRGO,neutral
1031608.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Fri., Dec. 21, 2018",2018-12-21 12:03:00-05:00,PRGO,positive
1031609.0,Mid-Day Market Update: U.S. Stocks Turns Lower; MICT Shares Spike Higher,2018-12-21 12:01:00-05:00,PRGO,neutral
1031610.0,Mid-Morning Market Update: Markets Open Higher; CarMax Earnings Beat Estimates,2018-12-21 10:17:00-05:00,PRGO,neutral
1031611.0,10 Biggest Price Target Changes For Friday,2018-12-21 09:48:00-05:00,PRGO,neutral
1031612.0,"Wells Fargo Maintains Market Perform on Perrigo Co, Lowers Price Target to $46",2018-12-21 09:20:00-05:00,PRGO,positive
1031613.0,Analysts Await Clarity On Perrigo Tax Liability Before Adjusting Ratings,2018-12-21 09:17:00-05:00,PRGO,positive
1031614.0,30 Stocks Moving In Friday's Pre-Market Session,2018-12-21 08:02:00-05:00,PRGO,neutral
1031615.0,Perrigo shares are trading lower after Irish regulators asked the company to pay around $1.87 billion in tax liabilities.,2018-12-21 07:47:00-05:00,PRGO,negative
1031616.0,Perrigo 8-K Shows Perrigo Pharma Int'l. Will Timely File An Appeal With Irish Tax Appeals Commission Related To Notice Of Amended Assessment For CY13,2018-12-20 16:56:00-05:00,PRGO,neutral
1031617.0,"Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018",2018-12-19 12:43:00-05:00,PRGO,negative
1031618.0,"Stocks Which Set New 52-Week Low The Last Trading Session, Fri., Dec. 7, 2018",2018-12-10 11:01:00-05:00,PRGO,negative
1031619.0,Perrigo Announces Launch An AB Rated Generic Version Of Topicort Topical Spray 0.25% For Plaque Psoriasis,2018-12-10 08:54:00-05:00,PRGO,neutral
1031620.0,"Stocks Trading Ex Dividend For Thurs., Nov. 29, 2018",2018-11-29 10:48:00-05:00,PRGO,neutral
1031621.0,"Stocks That Will Be Trading Ex Dividend Thurs., Nov. 29, 2018",2018-11-28 11:37:00-05:00,PRGO,neutral
1031622.0,"Perrigo Announces Patent Litigation Settlement For The Generic Version Of Sernivo Spray, 0.05%; Terms Not Disclosed",2018-11-28 08:47:00-05:00,PRGO,negative
1031623.0,Perrigo Announces Tentative FDA Approval For The First To File Generic Version Of Ultravate Lotion 0.05%  For Plaque Psoriasis,2018-11-26 09:02:00-05:00,PRGO,positive
1031624.0,"Stocks Which Set New 52-Week Low The Last Trading Session, Wed., Nov. 21, 2018",2018-11-23 09:09:00-05:00,PRGO,negative
1031625.0,"Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 19, 2018",2018-11-20 09:12:00-05:00,PRGO,negative
1031626.0,"Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 14, 2018",2018-11-15 11:37:00-05:00,PRGO,negative
1031627.0,UPDATE: 13F For Einhorn's Greenlight Shows Cut Stake In Perrigo From ~1.85M Shares To ~220K Shares,2018-11-14 17:12:00-05:00,PRGO,positive
1031628.0,"13F For David Einhorn's Greenlight Shows New Stake In Altice USA, Cut Stakes In GM, Perrigo, Liquidated Stakes In Best Buy, Dollar Tree, Gap",2018-11-14 16:19:00-05:00,PRGO,positive
1031629.0,10 Biggest Price Target Changes For Tuesday,2018-11-13 09:40:00-05:00,PRGO,neutral
1031630.0,"Benzinga's Top Upgrades, Downgrades For November 13, 2018",2018-11-13 09:18:00-05:00,PRGO,positive
1031631.0,"Morgan Stanley Maintains Equal-Weight on Perrigo Co, Lowers Price Target to $67",2018-11-13 09:00:00-05:00,PRGO,negative
1031632.0,"Berenberg Downgrades Perrigo Co to Hold, Lowers Price Target to $72",2018-11-13 06:42:00-05:00,PRGO,negative
1031633.0,"Perrigo Co CEO Kessler Buys 15,683 @ Avg Price: $63.79",2018-11-09 13:57:00-05:00,PRGO,neutral
1031634.0,80 Biggest Movers From Yesterday,2018-11-09 05:18:00-05:00,PRGO,neutral
1031635.0,65 Stocks Moving In Thursday's Mid-Day Session,2018-11-08 12:51:00-05:00,PRGO,neutral
1031636.0,Perrigo shares are down 7.5%after the company missed Q3 revenue estimates.,2018-11-08 11:09:00-05:00,PRGO,neutral
1031637.0,35 Stocks Moving In Thursday's Pre-Market Session,2018-11-08 08:02:00-05:00,PRGO,neutral
1031638.0,"Perrigo Sees CY18 Adj. EPS $4.45-$4.65, Cites 'primarily due to revised expectations for the RX segment'",2018-11-08 06:04:00-05:00,PRGO,neutral
1031639.0,"Perrigo Q3 EPS $1.09 Beats $1.01 Estimate, Sales $1.133B Miss $1.16B Estimate",2018-11-08 06:03:00-05:00,PRGO,negative
1031640.0,"Earnings Scheduled For November 8, 2018",2018-11-08 04:00:00-05:00,PRGO,neutral
1031641.0,Perrigo Q3 Earnings Preview,2018-11-07 13:31:00-05:00,PRGO,neutral
1031642.0,Sol-Gel Technologies Wins Collaboration With Perrigo,2018-11-01 17:29:00-04:00,PRGO,positive
1031643.0,Perrigo Confirms That Anacor Pharmaceuticals Has Initiated Patent Challenge For Generic Version Of Kerydin,2018-10-29 09:11:00-04:00,PRGO,positive
1031644.0,Perrigo Confirms  Adapt Pharma And Opiant Pharmaceuticals Initiated Patent Challenge For Generic Version Of Narcan,2018-10-26 09:24:00-04:00,PRGO,positive
1031645.0,"UPDATE: Emergent Notes Co.'s Adapt Units, Opiant Pharma, On Oct. 25, 2018, Filed Complaint For Patent Infringement Against Perrigo In US Related To Perrigo's ANDA Filing With FDA",2018-10-25 09:49:00-04:00,PRGO,negative
1031646.0,Emergent BioSolutions 8-K Shows Adapt Pharma Received Notice From Perrigo UK FINCO That Perrigo Filed Abbreviated New Drug Application Seeking Approval To Market Generic Version Of NARCAN Nasal Spray,2018-10-25 09:48:00-04:00,PRGO,positive
1031647.0,"Perrigo Announces The Launch Of An AB Rated Generic Version Of Androgel Topical Gel, 1.62%",2018-10-15 08:59:00-04:00,PRGO,neutral
1031648.0,FDA Commissioner Scott Gottlieb Issues Statement On 'new efforts to advance the development of generic copies of complex drugs to improve patient access to medicines',2018-10-09 11:19:00-04:00,PRGO,positive
1031649.0,Perrigo Appoints Murray S. Kessler As President And CEO,2018-10-08 17:03:00-04:00,PRGO,neutral
1031650.0,Perrigo Confirms Patent Challenge For Generic Version Of Jublia Topical Solution 10%,2018-10-01 10:27:00-04:00,PRGO,positive
1031651.0,Perrigo Announces Patent Litigation Settlement For Generic Version Of Picato Gel,2018-09-28 09:01:00-04:00,PRGO,negative
1031652.0,Health Care Has Been On Fire. Will The Uptrend Continue?,2018-09-07 14:40:00-04:00,PRGO,positive
1031653.0,"Perrigo Reports Final FDA Approval, Planned Launch For Store Brand OTC Equivalent Of Imodium Multi-Symptom Relief",2018-09-07 09:06:00-04:00,PRGO,positive
1031654.0,10 Biggest Price Target Changes For Tuesday,2018-08-21 09:41:00-04:00,PRGO,neutral
1031655.0,"Wells Fargo Maintains Market Perform on Perrigo Co, Lowers Price Target to $77",2018-08-21 07:32:00-04:00,PRGO,positive
1031656.0,"Perrigo Needs 'Meet-Or-Beat' Quarters, Deutsche Bank Says In Downgrade",2018-08-10 11:11:00-04:00,PRGO,neutral
1031657.0,"RBC Capital Maintains Sector Perform on Perrigo Co, Lowers Price Target to $67",2018-08-10 10:24:00-04:00,PRGO,negative
1031658.0,10 Biggest Price Target Changes For Friday,2018-08-10 09:59:00-04:00,PRGO,neutral
1031659.0,"Benzinga's Top Upgrades, Downgrades For August 10, 2018",2018-08-10 09:17:00-04:00,PRGO,positive
1031660.0,"Deutsche Bank Downgrades Perrigo Co to Hold, Lowers Price Target to $78",2018-08-10 07:54:00-04:00,PRGO,negative
1031661.0,77 Biggest Movers From Yesterday,2018-08-10 04:01:00-04:00,PRGO,neutral
1031662.0,68 Stocks Moving In Thursday's Mid-Day Session,2018-08-09 12:41:00-04:00,PRGO,neutral
1031663.0,UPDATE: Perrigo Said Sees CY18 Sales $4.8B-$4.9B,2018-08-09 09:49:00-04:00,PRGO,neutral
1031664.0,"Perrigo Shares Down 6%; Co. Earlier Announced Q2 Adj. EPS $1.22 Beats $1.19 Estimate, Sales $1.186B vs $1.23B Est.; Said Sees FY18 Adj. EPS $4.75-$4.95 vs $5.20 Est.",2018-08-09 09:48:00-04:00,PRGO,positive
1031665.0,"Perrigo Earlier Reported Q2 Adj. EPS $1.22 Beats $1.19 Estimate, Sales $1.186B Miss $1.23B Estimate",2018-08-09 09:46:00-04:00,PRGO,negative
1031666.0,Perrigo Co. PLC shares are trading 8% lower to $72.20 after missing quarterly revenue estimates.,2018-08-09 09:32:00-04:00,PRGO,negative
1031667.0,40 Stocks Moving In Thursday's Pre-Market Session,2018-08-09 08:09:00-04:00,PRGO,neutral
1031668.0,"10 Stocks To Watch For August 9, 2018",2018-08-09 04:57:00-04:00,PRGO,neutral
1031669.0,"Earnings Scheduled For August 9, 2018",2018-08-09 04:31:00-04:00,PRGO,neutral
1031670.0,Perrigo Announces Rx-To-OTC Switch Licensing For Nasonex,2018-08-09 04:02:00-04:00,PRGO,neutral
1031671.0,"Perrigo Announces Plan to Separate Prescription Pharmaceuticals Business; May Involve Separation to Shareholders, Sale or Merger",2018-08-09 03:58:00-04:00,PRGO,neutral
1031672.0,Perrigo's Q2 Earnings Preview,2018-08-08 15:05:00-04:00,PRGO,neutral
1031673.0,Argus Downgrades Perrigo Co to Hold,2018-07-30 09:14:00-04:00,PRGO,neutral
1031674.0,Perrigo Co Option Alert: Nov 16 $75 Calls at the Ask: 1000 @ $5.85 vs 47 OI; Earnings 8/9 Before Open [est] Ref=$75.7,2018-07-17 11:16:00-04:00,PRGO,positive
1031675.0,"Goldman Sachs Swaps Perrigo, Johnson & Johnson Ratings",2018-07-12 10:28:00-04:00,PRGO,neutral
1031676.0,8 Biggest Price Target Changes For Thursday,2018-07-12 10:04:00-04:00,PRGO,neutral
1031677.0,"Benzinga's Top Upgrades, Downgrades For July 12, 2018",2018-07-12 09:20:00-04:00,PRGO,positive
1031678.0,"Goldman Sachs Downgrades Perrigo Co to Sell, Lowers Price Target to $74",2018-07-12 08:21:00-04:00,PRGO,negative
1031679.0,"UPDATE: FTC Settlement For Amneal, Impax Deal Says ANI Pharma to Buy 7 Products, Perrigo To Buy Impax's Rights To 2 Products Which Were Partnered For, G&W Labs Will Buy Impax's Marketing Rights To 1 Product G&W Manufactures For Impax",2018-07-10 11:28:00-04:00,PRGO,neutral
1031680.0,FTC Says Perrigo Will Acquire Impax's Rights To 2 Products,2018-07-10 11:26:00-04:00,PRGO,neutral
1031681.0,"'We have advised Perrigo that it failed to comply with #FDA postmarketing requirements for a study intended to determine the cardiovascular effects of testosterone replacement therapy product, Testosterone Gel, by the agreed upon deadline.'-FDA's Gotlieb",2018-06-22 11:17:00-04:00,PRGO,negative
1031682.0,"Benzinga's Top Upgrades, Downgrades For June 6, 2018",2018-06-06 09:16:00-04:00,PRGO,positive
1031683.0,Barclays Downgrades Perrigo Co to Equal-Weight,2018-06-06 07:17:00-04:00,PRGO,neutral
1031684.0,"Perrigo Confirms Patent Challenge For Generic Version Of Sernivo Spray, 0.05%",2018-05-24 08:36:00-04:00,PRGO,positive
1031685.0,"Benzinga's Insider Buys Of The Week: JPMorgan, Philip Morris And More",2018-05-20 16:21:00-04:00,PRGO,neutral
1031686.0,"Wells Fargo Maintains Market Perform on Perrigo Co, Lowers Price Target to $84",2018-05-14 14:26:00-04:00,PRGO,positive
1031687.0,"Perrigo Reports Confirmation Of First-To-File Patent Challenge For Generic Version Of Ultravate Lotion, 0.05%",2018-05-14 09:30:00-04:00,PRGO,positive
1031688.0,26 Stocks Moving In Monday's Pre-Market Session,2018-05-14 08:18:00-04:00,PRGO,neutral
1031689.0,"UPDATE: Perrigo CRL From FDA Related To ANDA For Generic Version Of ProAir Aerosol; FDA Says Issues CRL To Indicate Review Cycle Complete, App Is Not Ready For Approval",2018-05-11 16:02:00-04:00,PRGO,negative
1031690.0,Perrigo Issues Warning Expects Complete Response Letter On Generic Version Of ProAir,2018-05-11 16:01:00-04:00,PRGO,negative
1031691.0,Perrigo Sees FY18 Adj. EPS $5.05-$5.45 vs $5.26 Est.,2018-05-08 08:39:00-04:00,PRGO,neutral
1031692.0,"Perrigo Q1 EPS $1.26 Beats $1.14 Estimate, Sales $1.217B Beat $1.21B Estimate",2018-05-08 08:34:00-04:00,PRGO,neutral
1031693.0,"Earnings Scheduled For May 8, 2018",2018-05-08 04:38:00-04:00,PRGO,neutral
1031694.0,Amneal And Impax Late Friday Received FTC Clearance For Business Combination,2018-04-30 08:56:00-04:00,PRGO,neutral
1031695.0,A Detailed Review Of Starboard Value's Stock Portfolio,2018-03-29 11:39:00-04:00,PRGO,neutral
1031696.0,"Perrigo CEO Roehrhoff Buys 7,500 @ Avg Price: $81.85 -Form4",2018-03-07 16:52:00-05:00,PRGO,neutral
1031697.0,"Perrigo Reports FDA Approval, Planned Launch For Store Brand OTC Equivalent Of Mucinex DM Maximum Strength ER Tablets",2018-03-07 08:50:00-05:00,PRGO,positive
1031698.0,"Perrigo Reports Q4 Adj. EPS $1.28 vs $1.25 Est., Sales $1.28B vs $1.25B Est.",2018-03-01 17:06:00-05:00,PRGO,neutral
1031699.0,42 Biggest Movers From Yesterday,2018-02-28 04:49:00-05:00,PRGO,neutral
1031700.0,35 Stocks Moving In Tuesday's Mid-Day Session,2018-02-27 12:32:00-05:00,PRGO,neutral
1031701.0,22 Stocks Moving In Tuesday's Pre-Market Session,2018-02-27 07:47:00-05:00,PRGO,neutral
1031702.0,"Earnings Scheduled For February 27, 2018",2018-02-27 04:01:00-05:00,PRGO,neutral
1031703.0,"Perrigo Confirms Patent Challenge For Generic Version Of Finacea Foam, 15%",2018-02-20 08:18:00-05:00,PRGO,positive
1031704.0,Perrigo Announces Ronald Winowiecki CFO,2018-02-20 08:07:00-05:00,PRGO,neutral
1031705.0,Perrigo Raises Qtr. Dividend From $0.16 To $0.19/Share,2018-02-15 09:20:00-05:00,PRGO,neutral
1031706.0,"Benzinga's Top Upgrades, Downgrades For February 1, 2018",2018-02-01 09:15:00-05:00,PRGO,positive
1031707.0,"Berenberg Initiates Coverage On Perrigo Co with Buy Rating, Announces $117.00 Price Target",2018-02-01 08:11:00-05:00,PRGO,neutral
1031708.0,"Perrigo Announces Tentative FDA Approval For The Generic Version Of Soolantra Cream, 1%",2018-01-30 08:18:00-05:00,PRGO,positive
1031709.0,Perrigo Reports Received Tentative FDA Approval For Generic Version Of Onexton Gel,2018-01-26 12:54:00-05:00,PRGO,positive
1031710.0,Perrigo Reports Final FDA Approval Of Generic Version Of Estrace Cream,2018-01-24 07:54:00-05:00,PRGO,positive
1031711.0,"Perrigo Reports Final FDA Approval, Launch Of AB-Rated Generic Version Of Epiduo",2018-01-24 07:46:00-05:00,PRGO,positive
1031712.0,"What Is Melvin Capital, And What Does It Want With Electronic Arts?",2018-01-05 14:34:00-05:00,PRGO,positive
1031713.0,"Leerink Swann Initiates Coverage On Perrigo Co with Market Perform Rating, Announces $90.00 Price Target",2018-01-03 08:40:00-05:00,PRGO,neutral
1031714.0,Perrigo Reports Tentative FDA Approval For Generic Version Of Prolensa Ophthalmic Solution 0.07%,2018-01-03 08:10:00-05:00,PRGO,positive
1031715.0,"Reuters, According To Sources, Reports Perrigo Is Preparing A Non-Binding Bid For Merck KGAA's Consumer Health Unit Ahead Of Dec. 15th Deadline",2017-12-14 12:36:00-05:00,PRGO,neutral
1031716.0,"Analyst: Despite Industry Woes, Investigations, And Management Shake-Up, Perrigo Is A Buy",2017-12-08 09:10:00-05:00,PRGO,positive
1031717.0,"Benzinga's Top Upgrades, Downgrades For December 8, 2017",2017-12-08 09:07:00-05:00,PRGO,positive
1031718.0,Argus Upgrades Perrigo Co to Buy,2017-12-08 07:15:00-05:00,PRGO,neutral
1031719.0,Perrigo Launches Generic Version Of Mycolog II Cream,2017-11-27 09:27:00-05:00,PRGO,neutral
1031720.0,13F Filing Shows Greenlight Capital Raises Stake In Perrigo To 2.9M Shares,2017-11-14 16:35:00-05:00,PRGO,positive
1031721.0,"RBC: Perrigo's Near-Term Risk Lessens, But Long-Term Issues Persist",2017-11-10 14:22:00-05:00,PRGO,negative
1031722.0,5 Biggest Price Target Changes For Friday,2017-11-10 09:46:00-05:00,PRGO,neutral
1031723.0,"Benzinga's Top Upgrades, Downgrades For November 10, 2017",2017-11-10 09:30:00-05:00,PRGO,positive
1031724.0,"The Market In 5 Minutes: Nvidia, Roku, Star Wars, And More",2017-11-10 09:13:00-05:00,PRGO,negative
1031725.0,"Morgan Stanley Maintains Equal-Weight on Perrigo Co PLC, Raises Price Target to $92.00",2017-11-10 08:29:00-05:00,PRGO,neutral
1031726.0,RBC Capital Upgrades Perrigo Co PLC to Market Perform,2017-11-10 06:16:00-05:00,PRGO,neutral
1031727.0,51 Biggest Movers From Yesterday,2017-11-10 05:30:00-05:00,PRGO,neutral
1031728.0,40 Stocks Moving In Thursday's Mid-Day Session,2017-11-09 12:32:00-05:00,PRGO,neutral
1031729.0,30 Stocks Moving In Thursday's Pre-Market Session,2017-11-09 08:14:00-05:00,PRGO,neutral
1031730.0,"Perrigo Shares Rise 10.69% to $89.88 Following Solid Earnings Beat, Strong Guidance",2017-11-09 04:46:00-05:00,PRGO,positive
1031731.0,Perrigo Reports Q3 Adj EPS $1.39 vs $1.11 Est; Revenue $1.2B vs $1.17B Est; Sees FY 2017 Adj EPS $4.80-$4.95 vs $4.59 Est,2017-11-09 04:32:00-05:00,PRGO,neutral
1031732.0,"Earnings Scheduled For November 9, 2017",2017-11-09 04:08:00-05:00,PRGO,neutral
1031733.0,Perrigo Announces Tentative FDA Approval for a First-to-File Generic Version of Picato Gel 0.05%,2017-11-02 08:35:00-04:00,PRGO,positive
1031734.0,"Perrigo Reports Patent Litigation Settlement For Generic Version Of Onexton Gel, Terms Confidential",2017-10-26 08:43:00-04:00,PRGO,negative
1031735.0,Perrigo Reports Tentative FDA Approval For First-To-File Generic Version Of Picato Gel .015%,2017-10-24 09:16:00-04:00,PRGO,positive
1031736.0,Perrigo Reports FDA Final Approval For AB-Rated Generic Version Of Exalgo 32mg Extended Release Tablets,2017-09-21 09:41:00-04:00,PRGO,positive
1031737.0,Perrigo Announces FDA Final Approval Of Generic Exalgo,2017-09-21 09:31:00-04:00,PRGO,positive
1031738.0,Perrigo Announces Tentative FDA Approval For Generic Acanya Gel,2017-09-18 08:49:00-04:00,PRGO,positive
1031739.0,Digesting Delivering Alpha 2017: The Top Picks You Need To Know,2017-09-13 08:44:00-04:00,PRGO,positive
1031740.0,Starboard Value's Jeff Smith At CNBC's 'Delivering Alpha' Conference Says Believes Perrigo's Valuation Is Dragged Down By Its Generics Business,2017-09-12 11:36:00-04:00,PRGO,negative
1031741.0,Starboard Value's Jeff Smith At CNBC's 'Delivering Alpha' Conference Highlights Amazon Is A Large Opportunity For Perrigo,2017-09-12 11:36:00-04:00,PRGO,positive
1031742.0,"Starboard Value's Jeff Smith Taking Stage At CNBC's 'Delivering Alpha' Conference, Mentions Perrigo As Best Idea",2017-09-12 11:31:00-04:00,PRGO,positive
1031743.0,"Benzinga's Top Upgrades, Downgrades For September 7, 2017",2017-09-07 09:25:00-04:00,PRGO,positive
1031744.0,"Oppenheimer Initiates Coverage On Perrigo Company plc Ordinary Shares with Outperform Rating, Announces $88.00 Price Target",2017-09-07 08:00:00-04:00,PRGO,positive
1031745.0,Perrigo Reports Final FDA Approval And Settlement For The Store Brand OTC Equivalent Of Nexium 24HR Capsules,2017-08-21 09:03:00-04:00,PRGO,positive
1031746.0,Perrigo Reports FDA Final Approval For AB-Rated Generic Version Of Mycolog II Cream,2017-08-16 08:53:00-04:00,PRGO,positive
1031747.0,5 Biggest Price Target Changes For Friday,2017-08-11 09:46:00-04:00,PRGO,neutral
1031748.0,"Benzinga's Top Upgrades, Downgrades For August 11, 2017",2017-08-11 09:28:00-04:00,PRGO,positive
1031749.0,"Wall Street's M&A Chatter From August 10: Perrigo, PayPal-Swift Financial, Invitation Homes-Starwood Waypoint",2017-08-11 07:42:00-04:00,PRGO,neutral
1031750.0,Goldman Sachs Upgrades Perrigo Company plc Ordinary Shares to Neutral,2017-08-11 07:01:00-04:00,PRGO,positive
1031751.0,Mid-Afternoon Market Update: NASDAQ Down 1.5%; Perrigo Shares Spike Higher,2017-08-10 14:42:00-04:00,PRGO,positive
1031752.0,18 Biggest Mid-Day Gainers For Thursday,2017-08-10 12:23:00-04:00,PRGO,neutral
1031753.0,Mid-Day Market Update: Babcock & Wilcox Drops After Q2 Results; Hudson Technologies Shares Surge,2017-08-10 12:05:00-04:00,PRGO,positive
1031754.0,"SK Capital Announces Agreement to Acquire Perrigo Company plc's Active Pharmaceutical Ingredients Business, Terms Not Disclosed",2017-08-10 10:40:00-04:00,PRGO,positive
1031755.0,Mid-Morning Market Update: Markets Open Lower; Macy's Tops Q2 Views,2017-08-10 10:14:00-04:00,PRGO,positive
1031756.0,10-Q From Perrigo Shows Co. Will Recognize Pre-Tax Restructuring Charges ~$55M-$65M,2017-08-10 09:38:00-04:00,PRGO,negative
1031757.0,Perrigo 10-Q Just Out,2017-08-10 09:37:00-04:00,PRGO,neutral
1031758.0,"Perrigo Shares Up 12.2% Premarket As Q2 Adj. EPS $1.22 Beat $0.93 Est., Sales Came In At $1.2B vs $1.18B Est.; Co. Sees FY17 Adj. EPS $4.45-$4.70 vs $4.28 Est.",2017-08-10 08:58:00-04:00,PRGO,positive
1031759.0,25 Stocks Moving In Thursday's Pre-Market Session,2017-08-10 08:04:00-04:00,PRGO,neutral
1031760.0,"Earnings Scheduled For August 10, 2017",2017-08-10 04:59:00-04:00,PRGO,neutral
1031761.0,Perrigo Reports Tentative FDA Approval For Generic Version Of Mirvaso Gel,2017-08-04 09:22:00-04:00,PRGO,positive
1031762.0,Perrigo Announces The Launch Of The AB Rated Generic Version Of Transderm Scop,2017-07-31 09:28:00-04:00,PRGO,neutral
1031763.0,"Companies Holding Shareholder Meetings Today Include BioPharmX, Ennis, Modine Manufacturing, Office Depot, Perrigo, Tessco Tech, The Trade Desk, Triumph Group, and VOXX Int'l",2017-07-20 08:32:00-04:00,PRGO,positive
1031764.0,Perrigo Reports FDA Final Approval Of AB-Rated Generic Version Of DermOtic Oil,2017-07-19 08:58:00-04:00,PRGO,positive
1031765.0,Perrigo Reports Settlement Of Generic Version Of Dymista Nasal Spray Patent Litigation,2017-07-17 09:07:00-04:00,PRGO,negative
1031766.0,The Royalty-Amassing Strategy Of Royalty Pharma,2017-07-10 16:11:00-04:00,PRGO,neutral
1031767.0,How Have The Best And Worst Stocks Of 2016 Performed In 2017?,2017-07-05 14:49:00-04:00,PRGO,neutral
1031768.0,Perrigo Launches Generic Version Of Axiron Topical Solution,2017-07-05 09:02:00-04:00,PRGO,positive
1031769.0,Perrigo Retains Advisory Firm For CEO Search,2017-06-21 09:52:00-04:00,PRGO,neutral
1031770.0,Perrigo Reports the Launch of Hydrocodone Bitartrate and Homatropine Methylbromide Oral Solution,2017-06-19 09:19:00-04:00,PRGO,positive
1031771.0,"Cantor Fitzgerald Initiates Coverage On Perrigo Company plc Ordinary Shares with Overweight Rating, Announces $85.00 Price Target",2017-06-16 06:28:00-04:00,PRGO,negative
1031772.0,Perrigo Announces CEO John Hendrickson to Retire; search Committee Has Been Formed to Find Replacement,2017-06-05 16:57:00-04:00,PRGO,neutral
1031773.0,12 Biggest Mid-Day Losers For Monday,2017-06-05 13:16:00-04:00,PRGO,negative
1031774.0,"Benzinga's Top Upgrades, Downgrades For June 5, 2017",2017-06-05 09:39:00-04:00,PRGO,positive
1031775.0,The Market In 5 Minutes,2017-06-05 09:08:00-04:00,PRGO,neutral
1031776.0,25 Stocks Moving In Monday's Pre-Market Session,2017-06-05 08:07:00-04:00,PRGO,neutral
1031777.0,RBC Capital Downgrades Perrigo Company plc Ordinary Shares to Underperform,2017-06-05 06:23:00-04:00,PRGO,positive
1031778.0,"Perrigo Shares Down ~1.5% Premarket; Co. Earlier Announced Filing of 10-K with Restated Financials, Reported Q4 Adj. EPS $1.24, Sales $1.3B vs $1.36B Est., Said Sees FY17 Adj. EPS $4.15-$4.50, Sales $4.6B-$4.8B",2017-05-23 08:40:00-04:00,PRGO,positive
1031779.0,20 Stocks Moving In Tuesday's Pre-Market Session,2017-05-23 08:04:00-04:00,PRGO,neutral
1031780.0,"Greenlight Opened New Stakes in Alere, Perrigo, Micron, Conduent",2017-05-15 16:14:00-04:00,PRGO,neutral
1031781.0,25 Stocks Moving In Wednesday's Pre-Market Session,2017-05-03 08:05:00-04:00,PRGO,neutral
1031782.0,Perrigo Sees Q1 Sales ~$1.2B vs $1.2B Est.; Sees FY17 Sales Excluding Tysabri $4.6B-$4.8B,2017-04-25 16:04:00-04:00,PRGO,neutral
1031783.0,"Perrigo Reports Restatement of 10-K, 10-Q; Offers FY17 Outlook",2017-04-25 16:03:00-04:00,PRGO,neutral
1031784.0,David Einhorn's Letter To Greenlight Investors Reveals New Perrigo Position,2017-04-25 13:16:00-04:00,PRGO,neutral
1031785.0,"Perrigo Shares Turn Positive, Now Up 1.2%; Hearing Greenlight's Q1 Shareholder Letter Shows Firm Has Taken Position",2017-04-25 11:35:00-04:00,PRGO,positive
1031786.0,Perrigo Completes Divestiture Of Tysabri Royalty Stream For Up To $2.85 Billion,2017-03-27 16:03:00-04:00,PRGO,neutral
1031787.0,"BZ NOTE on Perrigo Cancellation Report: in Mar. 16 Press Release, Co. Highlighted 'remains in a quiet period regarding these and any other financial matters until the filing of its Form 10-K'",2017-03-17 10:52:00-04:00,PRGO,positive
1031788.0,"Perrigo Shares Volatile Over Last Min as Traders Circulating Report Co. Cancelled Presentation at Oppenheimer Conference, Citing 10-K Filing Delay",2017-03-17 10:50:00-04:00,PRGO,negative
1031789.0,"Perrigo Says 'Continues to work with independent auditor, and expects to file its Form 10-K as soon as practical'",2017-03-16 16:02:00-04:00,PRGO,neutral
1031790.0,"Perrigo Says Previously Announced Its Auditors Notified Co. Historical Revenue Recognition Practices Were Being Evaluated, In Addition Co. Is Identifying Certain Deferred Tax Assets Associated With Tysabri And Omega Pharma; In Quiet Period 'Til Mar. 16",2017-03-07 16:20:00-05:00,PRGO,positive
1031791.0,Perrigo Shares Under Pressure Over Last Few Mins as Traders Circulating Seeking Alpha Post by DoctoRx 'Perrigo May Belong Much Closer To $20 Than $70',2017-03-07 13:47:00-05:00,PRGO,neutral
1031792.0,Hearing Perrigo Has Been Added To List of Generic Firms Investigated By U.S. Regulators,2017-03-03 10:28:00-05:00,PRGO,neutral
1031793.0,Why Perrigo Is Divesting Rights To The Best Multiple Sclerosis Drug,2017-03-02 15:38:00-05:00,PRGO,positive
1031794.0,7 Takeaways From Perrigo's Preliminary Q4 Results,2017-02-28 13:33:00-05:00,PRGO,neutral
1031795.0,20 Biggest Mid-Day Losers For Tuesday,2017-02-28 13:04:00-05:00,PRGO,negative
1031796.0,The Market In 5 Minutes,2017-02-28 09:24:00-05:00,PRGO,neutral
1031797.0,25 Stocks Moving In Tuesday's Pre-Market Session,2017-02-28 08:30:00-05:00,PRGO,neutral
1031798.0,"Amgen Says Newly Resigned Perrigo CFO Judy Brown To Join Co. Late April, Will Hear Global Business Services And Finance",2017-02-27 17:14:00-05:00,PRGO,positive
1031799.0,Perrigo To Reduce Global Workforce By ~750 Employees or 14% Of Non-Production Workforce,2017-02-27 16:34:00-05:00,PRGO,neutral
1031800.0,Perrigo Files For Non-Timely 10-Q,2017-02-27 16:29:00-05:00,PRGO,neutral
1031801.0,"Perrigo Reports Prelim  FY16 Adj. EPS $7.10-$7.25 vs. $7.10 Est., Sales ~$5.5B vs. $5.44B Est.",2017-02-27 16:10:00-05:00,PRGO,neutral
1031802.0,"Perrigo CFO Judy Brown Resigns, Names Ron Winowiecki Acting CFO",2017-02-27 16:04:00-05:00,PRGO,negative
1031803.0,Perrigo Signs Agreement To Divest Tysabri For Up To $2.85B With $2.2B Cash And $650M In Potential Milestones,2017-02-27 16:03:00-05:00,PRGO,positive
1031804.0,"Earnings Scheduled For February 27, 2017",2017-02-27 04:52:00-05:00,PRGO,neutral
1031805.0,Canaccord Genuity Initiates Coverage On Perrigo Company plc Ordinary Shares to Buy,2017-02-22 06:40:00-05:00,PRGO,positive
1031806.0,Perrigo Reports FDA Final Approval For Hydrocodone Bitartrate And Homatropine Methylbromide Oral Solution,2017-02-17 08:44:00-05:00,PRGO,positive
1031807.0,Michael Kors CEO: We're Actively Looking At M&A Options,2017-02-07 10:59:00-05:00,PRGO,positive
1031808.0,Perrigo Reports Confirmation of Patent Challenge for Generic Version of Onexton Gel,2017-02-07 08:18:00-05:00,PRGO,positive
1031809.0,"Perrigo Announces Agreement With Starboard, Will Add 3 Starboard Members Along With 2 Additional Independent Directors Recommended By Starboard",2017-02-07 08:08:00-05:00,PRGO,positive
1031810.0,Najarian Brothers See Unusual Options Activity In Perrigo And Restoration Hardware,2017-02-02 16:07:00-05:00,PRGO,neutral
1031811.0,Perrigo Reports FDA Approval Of Its First-To-File AB Rated Generic Version Of Topicort,2017-01-24 08:41:00-05:00,PRGO,positive
1031812.0,"Where There's Smoke, There's Not Always Fire: Be Careful With These 10 Rumor Mill Stocks",2017-01-20 10:10:00-05:00,PRGO,positive
1031813.0,Wall Street's M&A Chatter From January 19,2017-01-20 06:52:00-05:00,PRGO,neutral
1031814.0,Perrigo Shares Up ~0.7% Following Intereconomia Report of Chatter; BZ NOTE: Co. Was Target of Unconfirmed Chatter At Least 6 Times Over 2016,2017-01-19 11:13:00-05:00,PRGO,positive
1031815.0,Intereconomia Reporting Teva Rumored To Acquire Perrigo,2017-01-19 11:00:00-05:00,PRGO,neutral
1031816.0,Custopharm Acquires 2 Anda Pharmaceutical Products From Perrigo,2017-01-04 09:04:00-05:00,PRGO,neutral
1031817.0,The Year-End Tax-Selling Strategy,2017-01-02 10:42:00-05:00,PRGO,neutral
1031818.0,Perrigo's Weak Near-Term Outlook Is Concerning,2016-12-29 10:24:00-05:00,PRGO,negative
1031819.0,Should You Be Buying 2016 Market Leaders Or Laggards Heading Into 2017?,2016-12-28 13:55:00-05:00,PRGO,neutral
1031820.0,Option Alert: Perrigo Jan 85.0 Puts: 500 @  ASK  $3.80: 2753 traded vs 3018 OI:  Earnings 2/16 Before Open (est)  $83.23 Ref,2016-12-28 11:34:00-05:00,PRGO,positive
1031821.0,6 Worst Performing S&P 500 Stocks Of 2016,2016-12-27 10:41:00-05:00,PRGO,negative
1031822.0,Perrigo Announces FDA Approvals For The Store Brand OTC Equivalents To Nicorette White Ice Mint Gum,2016-12-20 09:00:00-05:00,PRGO,neutral
1031823.0,CNBC's List Of 20 Beaten-Up Stocks,2016-12-15 12:36:00-05:00,PRGO,neutral
1031824.0,Strides Shasun to Acquire Perrigo's US FDA Approved API Sacility in India for 1B Rupees,2016-12-09 04:26:00-05:00,PRGO,positive
1031825.0,Perrigo to Restructure Omega Pharma Belgium Business,2016-12-08 06:38:00-05:00,PRGO,neutral
1031826.0,"Worst Performing Industries For December 6, 2016",2016-12-06 11:15:00-05:00,PRGO,negative
1031827.0,"Worst Performing Industries For November 25, 2016",2016-11-25 11:23:00-05:00,PRGO,negative
1031828.0,"Top Performing Industries For November 23, 2016",2016-11-23 10:56:00-05:00,PRGO,positive
1031829.0,Hearing Perrigo Cancels Out Of Leerink Conference,2016-11-22 14:17:00-05:00,PRGO,negative
1031830.0,"Worst Performing Industries For November 16, 2016",2016-11-16 11:09:00-05:00,PRGO,negative
1031831.0,Some Of The Most Notable Changes This 13F Season,2016-11-15 15:06:00-05:00,PRGO,neutral
1031832.0,"Worst Performing Industries For November 15, 2016",2016-11-15 11:10:00-05:00,PRGO,negative
1031833.0,Starboard Value Reports 6.2% Stake in Perrigo in 13D,2016-11-15 04:29:00-05:00,PRGO,positive
1031834.0,Greenlight Capital Dissolves Small Perrigo Stake,2016-11-14 16:36:00-05:00,PRGO,neutral
1031835.0,Bank of America Upgrades Perrigo Company plc Ordinary Shares to Neutral,2016-11-11 08:56:00-05:00,PRGO,positive
1031836.0,18 Biggest Mid-Day Gainers For Thursday,2016-11-10 13:09:00-05:00,PRGO,neutral
1031837.0,"Top Performing Industries For November 10, 2016",2016-11-10 10:48:00-05:00,PRGO,positive
1031838.0,Perrigo Earlier Said Expecting CY16 Adj. EPS $6.85-$7.15,2016-11-10 07:57:00-05:00,PRGO,neutral
1031839.0,Perrigo Earlier Reported Will Review Strategic Alternatives for Tysabri Royalty System,2016-11-10 07:57:00-05:00,PRGO,neutral
1031840.0,Perrigo +4% Premaket @$86.85 Following Earnings Beat,2016-11-10 05:44:00-05:00,PRGO,neutral
1031841.0,Perrigo Reports Q3 EPS $1.65 vs $1.58 Est; Revenue $1.355B vs $1.28B	Est,2016-11-10 04:59:00-05:00,PRGO,neutral
1031842.0,"Earnings Scheduled For November 10, 2016",2016-11-10 04:16:00-05:00,PRGO,neutral
1031843.0,Option Alert: PRGO Nov16 85.0 Calls: 540 @  ASK  $3.80: 605 traded vs 219 OI:  Earnings tmrrw Before Open  $83.79 Ref,2016-11-09 13:42:00-05:00,PRGO,positive
1031844.0,"Pharma Stocks Up Post Election: Ariad 16%, Infinity Up 13%, Allergan, Progenics, Endo 10%, Pfizer, Regeneron 8%, AbbVie 7%, Mylan, Medicines Co. 6%, Perrigo, Merck 5%, Bristol-Myers, Eli Lilly, Sanofi, Novartis 3.5%",2016-11-09 09:41:00-05:00,PRGO,neutral
1031845.0,"Top Performing Industries For November 4, 2016",2016-11-04 10:54:00-04:00,PRGO,positive
1031846.0,"Top Performing Industries For November 1, 2016",2016-11-01 11:02:00-04:00,PRGO,positive
1031847.0,Perrigo Drops to Low of $88.91 on Volume,2016-10-28 10:15:00-04:00,PRGO,negative
1031848.0,Dealreporter Saying Perrigo Hires Bankers To Explore Strategic Alternatives,2016-10-21 11:58:00-04:00,PRGO,neutral
1031849.0,Perrigo Spikes to High of $92.59 on Volume,2016-10-21 11:56:00-04:00,PRGO,neutral
1031850.0,"Worst Performing Industries For October 14, 2016",2016-10-14 12:02:00-04:00,PRGO,negative
1031851.0,"Worst Performing Industries For October 7, 2016",2016-10-07 11:13:00-04:00,PRGO,negative
1031852.0,Perrigo Pops to High of $96.12 on Volume,2016-10-05 10:18:00-04:00,PRGO,neutral
1031853.0,Shares Pull Back As Problems Pile Up At Perrigo,2016-09-27 12:13:00-04:00,PRGO,negative
1031854.0,"Perrigo Reports Investment in Tarex Patented Technology, No Terms Disclosed",2016-09-27 08:17:00-04:00,PRGO,negative
1031855.0,"Top Performing Industries  For September 22, 2016",2016-09-22 11:32:00-04:00,PRGO,positive
1031856.0,Barclays Sees 44-48% Upside In Perrigo Shares; Co. Remains Vulnerable To Activist Investors,2016-09-19 14:03:00-04:00,PRGO,positive
1031857.0,Perrigo Shares Pull Back from High of $94.71; Reuters Reported Co Considering Sale of Tysabri Royalties,2016-09-16 15:50:00-04:00,PRGO,positive
1031858.0,Deutsche Bank Echoes Starboard's Sentiment: Perrigo Is Undervalued,2016-09-13 10:14:00-04:00,PRGO,neutral
1031859.0,Hedge Funds Issue Open Letters,2016-09-13 09:55:00-04:00,PRGO,neutral
1031860.0,Perrigo-Starboard Investment Merits A Closer Look,2016-09-12 12:59:00-04:00,PRGO,positive
1031861.0,12 Biggest  Mid-Day  Gainers For Monday,2016-09-12 12:28:00-04:00,PRGO,neutral
1031862.0,"Top Performing Industries For September 12, 2016",2016-09-12 11:42:00-04:00,PRGO,positive
1031863.0,Perrigo Shares Spike After Starboard Takes 4.6% Stake,2016-09-12 09:46:00-04:00,PRGO,positive
1031864.0,"Perrigo Acknowledges Receipt Of Letter From Starboard Value LP, Says They Look Forward To Constructive And Productive Dialogue With Starboard",2016-09-12 08:13:00-04:00,PRGO,positive
1031865.0,Can You Guess This Chart?,2016-09-12 07:23:00-04:00,PRGO,neutral
1031866.0,Starboard Letter to Perrigo Management,2016-09-12 06:53:00-04:00,PRGO,neutral
1031867.0,"Starboard Value Takes 4.6%, ~$600M Stake in Perrigo; Urges Perrigo to Refocus Business -DJ",2016-09-12 04:37:00-04:00,PRGO,positive
1031868.0,Perrigo Announces Tentative FDA Approval For Generic Version Of Epiduo Gel,2016-09-01 09:04:00-04:00,PRGO,positive
1031869.0,"Worst Performing Industries For August 29, 2016",2016-08-29 11:12:00-04:00,PRGO,negative
1031870.0,Martin Shkreli @MartinShkreli Tweet: $PRGO stock appears very expensive. I would short this stock.,2016-08-26 15:52:00-04:00,PRGO,neutral
1031871.0,Option Alert: PRGO Fri 8/26 85.0 Puts (Wkly): 1660 @  ASK  $0.10: 1661 traded vs 1686 OI: $88.04 Ref,2016-08-25 14:16:00-04:00,PRGO,positive
1031872.0,Perrigo Sells off to Low of $89.81 on Volume,2016-08-24 13:56:00-04:00,PRGO,negative
1031873.0,The Market In 5 Minutes: Stocks Trading Higher As Earnings Season Quiets Down,2016-08-24 09:07:00-04:00,PRGO,neutral
1031874.0,"Benzinga's M&A Chatter for Tuesday August 23, 2016",2016-08-23 19:19:00-04:00,PRGO,neutral
1031875.0,"10 Notable Stocks Trading Ex-Dividend Wednesday, August 24",2016-08-23 13:26:00-04:00,PRGO,neutral
1031876.0,Hearing Dealreporter Saying Mylan May Be Interested In Re-Engaging Perrigo According To A Sector Advisor,2016-08-23 11:16:00-04:00,PRGO,positive
1031877.0,Perrigo Confirms Patent Challenge For Generic Version Of Mirvaso Gel By Galderma Laboratories And Nestle Skin Health S.A.,2016-08-23 09:11:00-04:00,PRGO,positive
1031878.0,Perrigo Reports Tentative FDA Approval for Generic Version of Suprep,2016-08-23 09:11:00-04:00,PRGO,positive
1031879.0,14 Stocks Which Staged A Strong End Of The Week,2016-08-19 13:38:00-04:00,PRGO,positive
1031880.0,"Perrigo Reports Deal to Buy Geiss, Destin & Dunn, No Terms Disclosed",2016-08-17 07:47:00-04:00,PRGO,negative
1031881.0,Deutsche Thinks Perrigo's Lowered Expectations Are Beatable,2016-08-11 14:12:00-04:00,PRGO,negative
1031882.0,Northland Capital Downgrades Perrigo From Market Outperform To Market Perform,2016-08-11 11:26:00-04:00,PRGO,neutral
1031883.0,20 Biggest Mid-Day Losers For Wednesday,2016-08-10 13:06:00-04:00,PRGO,negative
1031884.0,"Worst Performing Industries For August 10, 2016",2016-08-10 11:11:00-04:00,PRGO,negative
1031885.0,Stocks Hitting 52-Week Lows,2016-08-10 10:20:00-04:00,PRGO,negative
1031886.0,"Pre-Market Losers Aug. 10, 2016: MYGN Down 28.28%, KORS 3.91%, SPWR 28.69%, PRGO 11.58%, OA 10.62%, OHRP 9.56%",2016-08-10 09:20:00-04:00,PRGO,negative
1031887.0,"The Market In 5 Minutes: Stocks Still In Tight Range, Disney And Michael Kors Fall On Earnings",2016-08-10 09:13:00-04:00,PRGO,neutral
1031888.0,22 Stocks Moving In Wednesday's Pre-Market Session,2016-08-10 08:25:00-04:00,PRGO,neutral
1031889.0,"Perrigo Sees FY 2016 EPS $6.85 to $7.15 vs $8.19 est, May Not Compare",2016-08-10 06:31:00-04:00,PRGO,neutral
1031890.0,"Perrigo Q2 EPS $1.93 vs $1.98 est, Revenue $1.48B vs $1.43B est",2016-08-10 06:30:00-04:00,PRGO,neutral
1031891.0,"10 Stocks To Watch For August 10, 2016",2016-08-10 05:19:00-04:00,PRGO,neutral
1031892.0,"Earnings Scheduled For August 10, 2016",2016-08-10 04:55:00-04:00,PRGO,neutral
1031893.0,Endo Spikes to High of $17.74 on Volume; Traders Attributing to Takeover Chatter; Perrigo Mentioned as Potential Buyer,2016-08-03 11:29:00-04:00,PRGO,neutral
1031894.0,Benzinga's Top Upgrades,2016-07-22 09:16:00-04:00,PRGO,positive
1031895.0,Deutsche Bank Upgrades Perrigo Co to Buy,2016-07-22 06:10:00-04:00,PRGO,neutral
1031896.0,"Worst Performing Industries For July 21, 2016",2016-07-21 11:38:00-04:00,PRGO,negative
1031897.0,"Worst Performing Industries For July 18, 2016",2016-07-18 11:33:00-04:00,PRGO,negative
1031898.0,Perrigo Announces FDA Final Approval And Launch Of The Store Brand Equivalent To Zegerid OTC Capsules,2016-07-18 08:53:00-04:00,PRGO,positive
1031899.0,The Market In 5 Minutes: Earnings Season Is Upon Us,2016-07-18 08:52:00-04:00,PRGO,neutral
1031900.0,Benzinga's Weekend M&A Chatter,2016-07-17 20:45:00-04:00,PRGO,neutral
1031901.0,"Proactive Investors Posts: 'Reckitt Benckiser ""set to bid for Perrigo""', Mentions PG, JNJ As Possible Bidders",2016-07-15 14:23:00-04:00,PRGO,positive
1031902.0,Perrigo Spikes to $96.43 on Vol,2016-07-15 14:19:00-04:00,PRGO,neutral
1031903.0,"Worst Performing Industries For June 30, 2016",2016-06-30 11:52:00-04:00,PRGO,negative
1031904.0,"Top Performing Industries For June 29, 2016",2016-06-29 11:05:00-04:00,PRGO,positive
1031905.0,Perrigo Delivered Notice to Alychlo NV and Holdco I BE NV Regarding Omega Pharma Invest Share Sale,2016-06-27 07:05:00-04:00,PRGO,positive
1031906.0,"Perrigo Reports FDA Clearance, Launch of Non-GMO Infant Formulas for US Store Brand Market",2016-06-21 08:30:00-04:00,PRGO,neutral
1031907.0,"Worst Performing Industries For June 20, 2016",2016-06-20 11:25:00-04:00,PRGO,negative
1031908.0,"Argus Sees Perrigo Going Lower After CEO Exit, Guidance Cut",2016-06-20 10:07:00-04:00,PRGO,negative
1031909.0,Benzinga's Top Downgrades,2016-06-20 09:10:00-04:00,PRGO,positive
1031910.0,UPDATE: Argus Downgrade on Perrigo Related to 'CEO exit and guidance cut',2016-06-20 07:59:00-04:00,PRGO,negative
1031911.0,"Perrigo Reports Divestiture of Vitamins, Minerals & Supplements Unit to IVC, No Terms Disclosed",2016-06-20 07:59:00-04:00,PRGO,negative
1031912.0,Argus Research Downgrades Perrigo Co to Hold,2016-06-20 07:14:00-04:00,PRGO,neutral
1031913.0,Option Alert: PRGO Fri 6/24 105 Calls (Wkly) Sweep: 586 @  ASK  $0.84: 742 traded vs 2403 OI:  Earnings 8/3  $97.82 Ref,2016-06-17 15:55:00-04:00,PRGO,positive
1031914.0,Perrigo Announces FDA Approval Of Ofirmev,2016-06-16 16:42:00-04:00,PRGO,positive
1031915.0,Perrigo Tanks As Confirmation Of Rumor Fails To Materialise,2016-06-15 15:04:00-04:00,PRGO,negative
1031916.0,7 Biggest Mid-Day Losers For Wednesday,2016-06-15 13:17:00-04:00,PRGO,negative
1031917.0,Raymond James Analysts Earlier Commented on Perrigo Chatter: '...we continue to harbor skepticism around the possibility of any face saving bid for Perrigo.',2016-06-15 12:41:00-04:00,PRGO,negative
1031918.0,"Worst Performing Industries For June 15,  2016",2016-06-15 11:21:00-04:00,PRGO,negative
1031919.0,"The Market In 5 Minutes: Janet Yellen, Exact Sciences And Some Graduation Advice",2016-06-15 09:03:00-04:00,PRGO,neutral
1031920.0,"Hearing ISI Doubtful of Perrigo Rumor, Shares Falling from $110 Level",2016-06-15 08:51:00-04:00,PRGO,negative
1031921.0,"Keep an Eye on These 7 Stocks for June 15, 2016",2016-06-15 04:25:00-04:00,PRGO,neutral
1031922.0,"Benzinga's M&A Chatter for Tuesday June 14, 2016",2016-06-14 20:23:00-04:00,PRGO,neutral
1031923.0,Perrigo Spokesperson Declines Comment Following Intraday Price Action Amid Vague Rumor of Takeover Interest,2016-06-14 17:31:00-04:00,PRGO,positive
1031924.0,Option Alert: PRGO Jun16 115 Calls Sweep: 694 @  ASK  $0.50: 1135 traded vs 337 OI:  Earnings 8/3  $103.39 Ref,2016-06-14 15:38:00-04:00,PRGO,positive
1031925.0,Watch for Near-Term Profit Taking in Perrigo Shares Following ~$8 Spike On The Heels of Vague Takeover Chatter,2016-06-14 15:34:00-04:00,PRGO,positive
1031926.0,Perrigo Spikes to High of $104.72; Hearing Takeover Chatter,2016-06-14 15:32:00-04:00,PRGO,neutral
1031927.0,Perrigo Shares Spiking Higher,2016-06-14 15:31:00-04:00,PRGO,positive
1031928.0,Perrigo Confirms First To File Patent Challenge For Generic Version Of Picato,2016-06-13 09:05:00-04:00,PRGO,positive
1031929.0,This Healthcare ETF Is Ready To Rebound,2016-05-23 08:11:00-04:00,PRGO,positive
1031930.0,Option Alert: PRGO Jun16 90.0 Calls Sweep: 962 @  ASK  $6.20: 989 traded vs 628 OI: $93.49 Ref,2016-05-18 13:03:00-04:00,PRGO,positive
1031931.0,"Top Performing Industries For May 18, 2016",2016-05-18 10:40:00-04:00,PRGO,positive
1031932.0,"Perrigo Shares Down In Pre-Market On 10Q Filing The Previous Night, Q1 GAAP Net Loss/Share Corrected To $2.34",2016-05-17 07:42:00-04:00,PRGO,positive
1031933.0,Is Valeant Haunted By Past And Future Ghosts? Gadfly Wonders,2016-05-13 12:20:00-04:00,PRGO,negative
1031934.0,UPDATE: Perrigo Says Still in Process of Finalizing Tax Impact Related to Omega Pharma Deal-Based Impairment Charges,2016-05-13 09:24:00-04:00,PRGO,negative
1031935.0,Perrigo Files Non-Timely 10Q,2016-05-13 09:19:00-04:00,PRGO,positive
1031936.0,"Worst Performing Industries For May 12, 2016",2016-05-12 11:15:00-04:00,PRGO,negative
1031937.0,The Market In 5 Minutes: Nothing's Impossible,2016-05-12 09:59:00-04:00,PRGO,neutral
1031938.0,Perrigo Reports Q1 EPS $1.75 vs $1.75 Est; Revenue $1.383B vs $1.35B Est,2016-05-12 06:04:00-04:00,PRGO,neutral
1031939.0,"Earnings Scheduled For May 12, 2016",2016-05-12 05:36:00-04:00,PRGO,neutral
1031940.0,"Forbes Article Says Perrigo Severely Overvalued As CEO Departs For Valeant, Perrigo Shares Falling To $93.62/Share",2016-05-09 13:29:00-04:00,PRGO,negative
1031941.0,"Top Performing Industries For May 9, 2016",2016-05-09 11:39:00-04:00,PRGO,positive
1031942.0,"Barron's Picks And Pans: Intercontinental Exchange, Visteon And More",2016-05-09 08:49:00-04:00,PRGO,neutral
1031943.0,"Worst Performing Industries For May 6, 2016",2016-05-06 11:58:00-04:00,PRGO,negative
1031944.0,"Perrigo, Allergan Report First-To-Market Launch Of Store Brand OTC Equivalent To Mucinex",2016-05-03 08:54:00-04:00,PRGO,neutral
1031945.0,Perrigo Reports FDA Approval and Launch of the Generic Version of BenzaClin,2016-05-02 09:03:00-04:00,PRGO,positive
1031946.0,Nothing Generic About This ETF's Long-Term Outlook,2016-04-28 08:14:00-04:00,PRGO,neutral
1031947.0,Perrigo Announces Resignation of Marc Coucke as the Executive VP and General Manager of the Branded Consumer Healthcare Business,2016-04-28 06:39:00-04:00,PRGO,negative
1031948.0,"Worst Performing Industries For April 27, 2016",2016-04-27 11:35:00-04:00,PRGO,negative
1031949.0,Stocks Hitting 52-Week Lows,2016-04-27 10:28:00-04:00,PRGO,negative
1031950.0,David Faber Reports Mylan Not Interested in Perrigo,2016-04-27 09:39:00-04:00,PRGO,negative
1031951.0,Option Alert: PRGO Jun16 100 Calls: 4000 @  ASK  $6.40: 5017 traded vs 384 OI:  Earnings today  $100.03 Ref,2016-04-26 15:28:00-04:00,PRGO,positive
1031952.0,Perrigo's CEO Departure Leaves More Questions Than Answers; BTIG Downgrades Stock,2016-04-26 11:07:00-04:00,PRGO,neutral
1031953.0,"Morgan Stanley Cuts Perrigo's Price Target To $112, Expects Lower Long-Term Growth",2016-04-26 09:25:00-04:00,PRGO,negative
1031954.0,"Amid Papa's Appointment, Rodman & Renshaw Still Buying Valeant",2016-04-26 08:22:00-04:00,PRGO,neutral
1031955.0,"Goldman Selling Perrigo, Prefers Mylan And Teva",2016-04-26 07:38:00-04:00,PRGO,neutral
1031956.0,"JP Morgan Maintains Neutral on Perrigo Co, Lowers PT to $105.00",2016-04-26 06:55:00-04:00,PRGO,positive
1031957.0,Jefferies Downgrades Perrigo Co to Hold,2016-04-26 05:59:00-04:00,PRGO,neutral
1031958.0,"Morgan Stanley Maintains Equal-weight on Perrigo Co, Lowers PT to $112.00",2016-04-26 04:37:00-04:00,PRGO,negative
1031959.0,"Barclays Maintains Overweight on Perrigo Co, Lowers PT to $120.00",2016-04-26 04:30:00-04:00,PRGO,negative
1031960.0,"After-Hours Recap: Index Movers, Earnings And Charter-Time Warner Cable Deal",2016-04-25 17:15:00-04:00,PRGO,neutral
1031961.0,"B. Riley Cuts Perrigo's Price Target From $146 To $113 On Papa's Exit, FY16 Guidance",2016-04-25 16:04:00-04:00,PRGO,negative
1031962.0,Mid-Afternoon Market Update: Crude Oil Down 2%; KKR Shares Slide Following Q1 Results,2016-04-25 14:31:00-04:00,PRGO,negative
1031963.0,Pharma Names Under Pressure Amid Perrigo Warning,2016-04-25 13:53:00-04:00,PRGO,negative
1031964.0,"B. Riley's Linda Bolton Weiser Cuts Estimates And Price Target, From $146 To $113 On Joseph Papa's Exit & FY16 Guidance",2016-04-25 13:47:00-04:00,PRGO,negative
1031965.0,Stifel Nicolaus Downgrades Perrigo Co to Hold,2016-04-25 13:34:00-04:00,PRGO,neutral
1031966.0,BTIG Research Downgrades Perrigo Co to Neutral,2016-04-25 12:57:00-04:00,PRGO,neutral
1031967.0,Mid-Day Market Update: Tribune Publishing Jumps Following Gannett's Takeover Proposal; TrovaGene Shares Drop,2016-04-25 12:02:00-04:00,PRGO,neutral
1031968.0,Who Is Joe Papa?,2016-04-25 11:53:00-04:00,PRGO,neutral
1031969.0,"Worst Performing Industries For April 25, 2016",2016-04-25 11:12:00-04:00,PRGO,negative
1031970.0,Valeant's Gain Is Perrigo's Loss,2016-04-25 10:55:00-04:00,PRGO,positive
1031971.0,Stocks Hitting 52-Week Lows,2016-04-25 10:18:00-04:00,PRGO,negative
1031972.0,Mid-Morning Market Update: Markets Open Lower; Xerox Profit Misses Views,2016-04-25 10:06:00-04:00,PRGO,negative
1031973.0,"The Market In 5 Minutes: Monday, April 25, 2016",2016-04-25 09:55:00-04:00,PRGO,neutral
1031974.0,"Joseph Papa Resigns As Perrigo CEO, Joins Valeants As Chairman And CEO",2016-04-25 09:53:00-04:00,PRGO,negative
1031975.0,Wells Fargo Downgrades Perrigo Co to Market Perform,2016-04-25 09:49:00-04:00,PRGO,positive
1031976.0,Hearing Wells Fargo Downgrades Perrigo From Outperform To Market Perform,2016-04-25 09:47:00-04:00,PRGO,positive
1031977.0,"Bronte Capital's John Hempton on Valeant: Says He's Glad His Short Is Mostly Covered, 'Joe Papa is a fabulous appointment - far better than Valeant deserved.'",2016-04-25 09:10:00-04:00,PRGO,positive
1031978.0,10 Stocks Moving In Monday's Pre-Market Session,2016-04-25 08:15:00-04:00,PRGO,neutral
1031979.0,Perrigo Updates FY16 Outlook: Cuts Adj. EPS Guidance from $9.50-$10.10 (as of Jan. 11) to $8.20-$8.60 vs $9.52 Est.,2016-04-25 07:48:00-04:00,PRGO,negative
1031980.0,"Perrigo Sees Q1 EPS $1.71-$1.77 vs $1.89 Est., Sales $1.33B-$1.35B vs $1.4B Est.",2016-04-25 07:47:00-04:00,PRGO,neutral
1031981.0,"Perrigo Reports Resignation of Chair, CEO Joseph Papa; Pres John Hendrickson Named as CEO, Laurie Brlas Named Chair; BZ NOTE: Specific Reason for Papa Resignation Not Mentioned, Valeant Not Named in Release",2016-04-25 07:46:00-04:00,PRGO,negative
1031983.0,Cramer: What To Know About Perrigo,2016-04-22 14:07:00-04:00,PRGO,neutral
1031984.0,"Worst Performing Industries For April 22, 2016",2016-04-22 11:22:00-04:00,PRGO,negative
1031985.0,Perrigo Sells off to Low of $120.93,2016-04-22 09:01:00-04:00,PRGO,negative
1031986.0,"Valeant Spikes 6%, WSJ Says Company Close To Hiring Perrigo's Chief As New CEO",2016-04-22 08:06:00-04:00,PRGO,neutral
1031987.0,"Perrigo Responds to Media Speculation Related to Chair, CEO Joseph Papa: '...we do not comment on speculation or market rumor.'",2016-04-22 06:01:00-04:00,PRGO,neutral
1031988.0,Valeant Could Name Perrigo's Joseph Papa as its New CEO as Soon as Next Week -Wall Street Journal,2016-04-22 04:35:00-04:00,PRGO,neutral
1031989.0,Perrigo Reports Launch Of OTC Store Brand Equivalent To Glucerna Aseptic Adult Nutritional Shake,2016-04-12 08:22:00-04:00,PRGO,negative
1031990.0,"Worst Performing Industries For April 11, 2016",2016-04-11 11:16:00-04:00,PRGO,negative
1031991.0,Israel Remains A Developed Market Opportunity,2016-04-08 06:19:00-04:00,PRGO,positive
1031992.0,"Top Performing Industries For April 7, 2016",2016-04-07 11:14:00-04:00,PRGO,positive
1031993.0,"Argus Research Maintains Buy on Perrigo Co, Lowers PT to $160.00",2016-04-06 06:59:00-04:00,PRGO,negative
1031994.0,"Worst Performing Industries For April 5, 2016",2016-04-05 11:17:00-04:00,PRGO,negative
1031995.0,"Top Performing Industries For April 4, 2016",2016-04-04 10:32:00-04:00,PRGO,positive
1031996.0,"Worst Performing Industries For March 28, 2016",2016-03-28 10:44:00-04:00,PRGO,negative
1031997.0,"Perrigo, Allergan Report First-To-Market Launch Of Store Brand OTC Equivalent To Mucinex 1200mg ER Tablets",2016-03-23 08:32:00-04:00,PRGO,neutral
1031998.0,Perrigo Pops to High of $131.23,2016-03-09 10:26:00-05:00,PRGO,neutral
1031999.0,BTIG Recommends 'Beaten Down' Drug Manufacturers Like Teva,2016-03-07 10:31:00-05:00,PRGO,positive
1032000.0,"Top Performing Industries For February 24, 2016",2016-02-24 10:54:00-05:00,PRGO,positive
1032001.0,"The Stocks That Moved The S&P, Dow And Nasdaq Today",2016-02-22 16:34:00-05:00,PRGO,neutral
1032002.0,UPDATE: FTC's Modified Final Order Shows Mylan Must Submit Annual Compliance Reports for Three Years Instead of Ten Years,2016-02-22 12:08:00-05:00,PRGO,neutral
1032003.0,Hearing FTC Has Approved Modified Final Order Which Settled Charges Related to Mylan's Proposed Hostile Bid for Perrigo Would Hurt Competition,2016-02-22 12:07:00-05:00,PRGO,negative
1032004.0,"Worst Performing Industries For February 22, 2016",2016-02-22 11:17:00-05:00,PRGO,negative
1032005.0,Benzinga's Top Downgrades,2016-02-22 09:26:00-05:00,PRGO,positive
1032006.0,"Goldman Sachs Downgrades Perrigo Co to Sell, Lowers PT to $124.00",2016-02-22 06:16:00-05:00,PRGO,negative
1032007.0,Benzinga's Top Downgrades,2016-02-19 08:48:00-05:00,PRGO,positive
1032008.0,Wells Fargo Initiates Coverage on Perrigo Co at Outperform,2016-02-19 08:40:00-05:00,PRGO,positive
1032009.0,"Wells Fargo Initiates AGN, TEVA, MNK, PRGO at Outperform; Starts VRX At Underperform; Starts MYL At Market Perform",2016-02-19 08:00:00-05:00,PRGO,positive
1032010.0,"B. Riley Downgrades Perrigo Co to Neutral, Lowers PT to $146.00",2016-02-19 05:55:00-05:00,PRGO,negative
1032011.0,"Deutsche Bank Maintains Buy on Perrigo Co, Lowers PT to $172.00",2016-02-18 15:28:00-05:00,PRGO,negative
1032012.0,Mid-Afternoon Market Update: Perrigo Slips On Earnings Miss; Sunedison Semiconductor Shares Surge,2016-02-18 14:39:00-05:00,PRGO,positive
1032013.0,Mid-Day Market Update: Jack in the Box Falls On Weak Results; Ingram Micro Shares Spike Higher,2016-02-18 12:07:00-05:00,PRGO,negative
1032014.0,"Worst Performing Industries For February 18, 2016",2016-02-18 11:16:00-05:00,PRGO,negative
1032015.0,Perrigo Tumbles 6% Following Q4 Miss,2016-02-18 08:38:00-05:00,PRGO,negative
1032016.0,10 Stocks Moving In Thursday's Pre-Market Session,2016-02-18 08:27:00-05:00,PRGO,neutral
1032017.0,Perrigo Sees CY16 Adj. EPS $9.50-$9.80 vs $9.74 Est.,2016-02-18 06:03:00-05:00,PRGO,neutral
1032018.0,"Perrigo Reports Q4 Adj. EPS $1.80 vs $1.93 Est., Sales $1.42B vs $1.46B Est.",2016-02-18 06:03:00-05:00,PRGO,neutral
1032019.0,"Earnings Scheduled For February 18, 2016",2016-02-18 04:09:00-05:00,PRGO,neutral
1032020.0,Meeting With Mylan Management Shows This Is The Stock's Biggest Problem,2016-02-16 09:25:00-05:00,PRGO,negative
1032021.0,Perrigo Declines Comment on Rumored Bid for Endo,2016-01-26 14:00:00-05:00,PRGO,neutral
1032022.0,Hearing Unconfirmed Market Chatter of Perrigo $79/Share Bid for Endo,2016-01-26 12:05:00-05:00,PRGO,negative
1032023.0,UPDATE: Perrigo Spokesperson Says Tentative Earnings on February 18; Says Hard to be at Conference the Week Before,2016-01-22 14:07:00-05:00,PRGO,negative
1032024.0,Perrigo Spikes After Rumors It's Withdrawing From Leerink Conference,2016-01-22 12:29:00-05:00,PRGO,neutral
1032025.0,Hearing Leerink Said Perrigo Canceled Out of Healthcare Conference as it Fell During Quiet Period Ahead of Earnings,2016-01-22 11:54:00-05:00,PRGO,neutral
1032026.0,Hearing Unconfirmed Chatter PRGO Cancelled Appearance At Leerink Conf.,2016-01-22 11:08:00-05:00,PRGO,negative
1032027.0,Benzinga's Top Initiations,2016-01-21 09:33:00-05:00,PRGO,positive
1032028.0,"Barclays Initiates Coverage on Perrigo Co at Overweight, Announces $180.00 PT",2016-01-21 05:24:00-05:00,PRGO,negative
1032029.0,New ETF Is A Refined Pharmaceuticals Play,2016-01-14 10:00:00-05:00,PRGO,positive
1032030.0,Perrigo Starts Voluntary Product Recall In The U.S. Of Children's Guaifenesin Grape Liquid And Guaifenesin DM Cherry Liquid Due To A Potential Defect With The Dosage Cup,2016-01-11 12:07:00-05:00,PRGO,negative
1032031.0,Perrigo CEO Papa Sees M&A Opportunity in Europe in Consumer Healthcare,2016-01-11 11:25:00-05:00,PRGO,positive
1032032.0,Perrigo CEO Sees M&A Value In Europe For Consumer Healthcare,2016-01-11 11:24:00-05:00,PRGO,positive
1032033.0,Perrigo Increases FY16 Adj. EPS From $9.30 To $9.50-$10.10,2016-01-11 09:22:00-05:00,PRGO,neutral
1032034.0,"Top Performing Industries For January 5, 2016",2016-01-05 10:31:00-05:00,PRGO,positive
1032035.0,"UPDATE: Separately, Perrigo Reports Suspension Of Sales Of Guaifenesin 600mg Extended Relaes Pending Resolution Of Challenges Related To Excipient Used In Production Of Product, Expected To Have Minimal Impact On Q4 EPS",2016-01-04 08:26:00-05:00,PRGO,positive
1032036.0,"Allergan, Perrigo Report First-To-Market Launch Of Store Brand Equivalent To Mucinex D 600mg ER Tablets",2016-01-04 08:24:00-05:00,PRGO,neutral
1032037.0,"Active Fund Managers Focus On Materials And Utilities, Shy Away From Telecom",2015-12-30 14:51:00-05:00,PRGO,positive
1032038.0,Why Underweight Stocks Will Continue To Outperform Overweight Stocks,2015-12-30 08:42:00-05:00,PRGO,negative
1032039.0,"Perrigo Shares Positive Throughout Tuesday's Session Following Earlier New Outperform Rating, $195 Target at Northland",2015-12-22 14:12:00-05:00,PRGO,positive
1032040.0,UPDATE: Perrigo Deal Expected To Generate Sales Of Greater Than $60M And Adj. EPS Accretion Of $0.20 Within First Year Post-Close,2015-12-17 08:55:00-05:00,PRGO,positive
1032041.0,"Perrigo Reports Purchase of Generic Retin-A Portfolio, No Terms Disclosed",2015-12-17 08:55:00-05:00,PRGO,negative
1032042.0,"Hearing AstraZeneca Has Reported Closing of Deal with Perrigo, Says Deal Does Not Impact Outlook",2015-12-15 10:08:00-05:00,PRGO,neutral
1032043.0,Benzinga's Top Upgrades,2015-12-10 09:52:00-05:00,PRGO,positive
1032044.0,"Argus Upgrades Perrigo, Stock Is At A Favorable Entry Point",2015-12-10 08:07:00-05:00,PRGO,positive
1032045.0,"Argus Research Upgrades Perrigo Co to Buy, Announces $170.00 PT",2015-12-10 07:18:00-05:00,PRGO,neutral
1032046.0,"Morgan Stanley Assumes Perrigo Co at Equal-weight, Announces $167.00 PT",2015-12-03 09:36:00-05:00,PRGO,neutral
1032047.0,"EXCLUSIVE: FBB's Mike Bailey On Pfizer-Allergan Deal, Taxes, Rate Hike And Biotech Picks",2015-11-25 09:53:00-05:00,PRGO,positive
1032048.0,"FBB Capital's Bailey Believes Next Mega-Cap Deal in Pharma Could Be 'Awhile,' Sees Mylan, Perrigo as Next Takeover Targets",2015-11-24 13:46:00-05:00,PRGO,neutral
1032049.0,"Perrigo Reports Purchase of Entocort Capsules, Authorized Generic Capsules Marketed by Par Pharma from AstraZeneca for $380M",2015-11-23 07:58:00-05:00,PRGO,neutral
1032050.0,Benzinga's Top Upgrades,2015-11-18 08:46:00-05:00,PRGO,positive
1032051.0,"B. Riley Upgrades Perrigo Co to Buy, Raises to $(aN)",2015-11-18 06:21:00-05:00,PRGO,neutral
1032052.0,Morning Market Gainers,2015-11-16 09:47:00-05:00,PRGO,neutral
1032053.0,Benzinga's Top Upgrades,2015-11-16 08:54:00-05:00,PRGO,positive
1032054.0,Benzinga's Top #PreMarket Gainers,2015-11-16 08:14:00-05:00,PRGO,positive
1032055.0,"UBS Upgrades Perrigo Co to Buy, Maintains $200.00 PT",2015-11-16 07:49:00-05:00,PRGO,neutral
1032056.0,Benzinga's Weekend M&A Chatter,2015-11-15 20:01:00-05:00,PRGO,neutral
1032057.0,Loeb's Third Point Liquidates Perrigo Position,2015-11-13 16:59:00-05:00,PRGO,neutral
1032058.0,"Worst Performing Industries For November 13, 2015",2015-11-13 12:28:00-05:00,PRGO,negative
1032059.0,Mid-Day Market Update: Planet Fitness Surges On Upbeat Results; Fossil Group Shares Slide,2015-11-13 12:26:00-05:00,PRGO,positive
1032060.0,Benzinga's Volume Movers,2015-11-13 10:23:00-05:00,PRGO,neutral
1032061.0,Mid-Morning Market Update: Markets Open Lower; J C Penney Revenue Tops Views,2015-11-13 10:04:00-05:00,PRGO,positive
1032062.0,Morning Market Losers,2015-11-13 09:51:00-05:00,PRGO,negative
1032063.0,Morning Market Gainers,2015-11-13 09:42:00-05:00,PRGO,neutral
1032064.0,"Perrigo Shareholders Convincingly Reject Mylan's Tender Offer, Expressing Confidence in Perrigo's Long-Term Strategy",2015-11-13 09:23:00-05:00,PRGO,positive
1032065.0,Mylan To Lose Hostile Takeover Of Perrigo,2015-11-13 09:03:00-05:00,PRGO,negative
1032066.0,Benzinga's Top #PreMarket Losers,2015-11-13 08:20:00-05:00,PRGO,negative
1032067.0,Benzinga's Top #PreMarket Gainers,2015-11-13 08:14:00-05:00,PRGO,positive
1032068.0,Perrigo -6.8% Premarket Following Report of Expected Failed Tender Offer by Mylan,2015-11-13 06:33:00-05:00,PRGO,negative
1032069.0,"Only 40% of Perrigo's Shares Said to have been Tendered Ahead of Mylan Deadline; Takeover Bid Unlikely to Succeed, According to Sources -Reuters",2015-11-13 04:26:00-05:00,PRGO,positive
1032070.0,"Top Performing Industries For November 12, 2015",2015-11-12 10:47:00-05:00,PRGO,positive
1032071.0,Perrigo Reports FDA Approval of AB-Rated Generic Version of KlorCon ER Tablets,2015-11-10 08:25:00-05:00,PRGO,positive
1032072.0,"Perrigo Sends Letter to Holders, Discusses Mylan Deal; Says 'Corporate Governance, Mylan Style: A Question Of Trust",2015-11-09 07:05:00-05:00,PRGO,positive
1032073.0,Perrigo Responds to Misleading Statements,2015-11-09 06:56:00-05:00,PRGO,negative
1032074.0,Mylan Reports Received FTC Clearance for Proposed Deal with Perrigo,2015-11-03 15:19:00-05:00,PRGO,neutral
1032076.0,Hearing FTC to Require Mylan to Sell Rights to Seven Generic Pharmas Related to Perrigo Deal,2015-11-03 14:02:00-05:00,PRGO,neutral
1032077.0,Option Alert: $PRGO Nov $160 Call Sweep; 1015 Contracts @Ask @$6.70,2015-11-02 15:02:00-05:00,PRGO,positive
1032078.0,Mylan Shares to Begin Trading on Tel Aviv Stock Exchange on November 4 -Reuters,2015-11-02 04:59:00-05:00,PRGO,positive
1032079.0,"Worst Performing Industries For October 30, 2015",2015-10-30 11:01:00-04:00,PRGO,negative
1032080.0,Mylan Says Remains Steadfastly Committed to Offer for Perrigo,2015-10-30 07:05:00-04:00,PRGO,positive
1032081.0,Mylan Reports NY District Court Denied Motion by Perrigo for Prelim. Injunction Related to Deal,2015-10-30 06:45:00-04:00,PRGO,negative
1032082.0,"Top Performing Industries For October 29, 2015",2015-10-29 10:47:00-04:00,PRGO,positive
1032083.0,UPDATE: Tel Aviv District Court Rules in Favor of Mylan Listing on Tel Aviv Stock Exchange,2015-10-28 15:15:00-04:00,PRGO,positive
1032084.0,Perrigo CEO Tells Shareholders Not to Vote in Favor of Mylan Bid -Reuters,2015-10-27 09:52:00-04:00,PRGO,positive
1032085.0,11 Large-Caps Trading At Bargain Bin Prices,2015-10-22 13:39:00-04:00,PRGO,positive
1032086.0,From Conf Call: Perrigo Says Almost All Revenues Insulated from Current Pricing Drama,2015-10-22 08:16:00-04:00,PRGO,neutral
1032087.0,UPDATE: Perrigo Names John Hendrickson President,2015-10-22 06:11:00-04:00,PRGO,neutral
1032088.0,"UPDATE: Perrigo Begins Sale Process for US Vitamins, Minerals and Supplements Business",2015-10-22 06:10:00-04:00,PRGO,neutral
1032089.0,Perrigo to Reduce Workforce by ~800 Employees,2015-10-22 06:09:00-04:00,PRGO,neutral
1032090.0,"Perrigo Q3 EPS $1.76 vs $1.73 est, Revenue $1.3B vs $1.4B est, Narrows Guidance",2015-10-22 06:06:00-04:00,PRGO,neutral
1032091.0,"Earnings Scheduled For October 22, 2015",2015-10-22 05:00:00-04:00,PRGO,neutral
1032092.0,Perrigo Urges Federal Judge in Manhattan to Stop Mylan from Pursuing Bid Until it Corrects Misleading Statements Made to Perrigo Shareholders -Reuters,2015-10-21 14:01:00-04:00,PRGO,negative
1032093.0,"Worst Performing Industries For October 21, 2015",2015-10-21 12:27:00-04:00,PRGO,negative
1032095.0,Mylan Highlights Clear Value Creation to Perrigo Shareholders Available Through its Offer,2015-10-13 16:19:00-04:00,PRGO,positive
1032096.0,Irish Takeover Panel Rejects Perrigo's Request to Declare Mylan's Unsolicited Tender Offer to have Lapsed -Reuters,2015-10-13 06:30:00-04:00,PRGO,negative
1032097.0,"Perrigo, Flamel Enter Into Exclusive Licensing Agreement for LiquiTime Extended Release Suspension Technology in the U.S. OTC Market",2015-10-05 09:56:00-04:00,PRGO,positive
1032098.0,Spokesperson from York Capital Declines Comment Following Reuters Report Tues. Suggesting Large Shareholder(s) in Co. Urging Mgmt to Explore Sale,2015-09-30 09:38:00-04:00,PRGO,neutral
1032099.0,"Spokesperson from Wellington Management Group, a Large Holder in Perrigo, Declines Comment on Speculation Related to Rumor of Investor Interest in Mgmt Pursuing Sale",2015-09-29 12:38:00-04:00,PRGO,positive
1032100.0,Mylan Shares Mute Following Perrigo Sale Chatter,2015-09-29 12:26:00-04:00,PRGO,positive
1032101.0,"Perrigo Shares Spiking Higher, HOD $162.69, Currently $156.36",2015-09-29 12:24:00-04:00,PRGO,positive
1032102.0,Hearing Perrigo Holder is Calling for Co. to Explore Sale,2015-09-29 12:22:00-04:00,PRGO,neutral
1032103.0,"Worst Performing Industries For September 28, 2015",2015-09-28 12:00:00-04:00,PRGO,negative
1032104.0,Benzinga's Weekend M&A Chatter,2015-09-27 18:53:00-04:00,PRGO,neutral
1032105.0,"Perrigo Commenced Litigation Against Mylan, Israeli Securities Authority Seeking Declaratory, Injunctive Relief, Says Mylan Failed to Publish Lawful Tender Offer in Israel On September 14, 2015",2015-09-25 14:55:00-04:00,PRGO,positive
1032106.0,UPDATE: Mylan Says Suit 'Entirely Without Merit...Mylan's Offer in Israel is Valid and Proper in All Respects',2015-09-24 15:22:00-04:00,PRGO,positive
1032107.0,Mylan Offers Comment on 'Meritless' Perrigo Suit,2015-09-24 15:21:00-04:00,PRGO,neutral
1032108.0,"Perrigo Announces FDA Approval, Launch of the AB Rated Generic Version of BenzaClin Topical Gel",2015-09-22 08:32:00-04:00,PRGO,positive
1032109.0,"Benzinga's M&A Chatter for Thursday September 17, 2015",2015-09-17 19:11:00-04:00,PRGO,neutral
1032110.0,Perrigo Maints FY 2015 Guidance EPS $7.50 to $8,2015-09-17 06:18:00-04:00,PRGO,neutral
1032111.0,Perrigo Issues Statment On Mylan,2015-09-17 06:16:00-04:00,PRGO,neutral
1032112.0,"Worst Performing Industries For September 16, 2015",2015-09-16 11:40:00-04:00,PRGO,negative
1032113.0,Endo Pharma May Be In Talks To Sell Itself To Perrigo For $100+/Share According To RBC - UNCONFIRMED,2015-09-16 09:35:00-04:00,PRGO,negative
1032114.0,Mylan-Perrigo Buyout Offer: What's Next?,2015-09-14 11:51:00-04:00,PRGO,neutral
1032115.0,Perrigo Announcement Regarding Unsolicited Offer From Mylan N.V.,2015-09-14 09:44:00-04:00,PRGO,neutral
1032116.0,Mylan Begins Offer To Acquire Perrigo For $75/Share Cash & 2.3 Mylan Ordinary Shares For Each Perrigo Share,2015-09-14 08:31:00-04:00,PRGO,positive
1032117.0,"Allergan, Perrigo Announce Receiving FDA Approval of Three-ER Products Equal to Mucinex, Mucinex DM",2015-09-10 16:35:00-04:00,PRGO,positive
1032118.0,"UPDATE: Perrigo's Chair, Pres, CEO Papa Clarifies Numerous Misleading Statements, Reiterates Co.'s Confidence Holders Will Not Tender Mylan's Bid",2015-09-10 07:57:00-04:00,PRGO,positive
1032119.0,Perrigo Response To Mylan Executive Chairman Letter,2015-09-10 07:56:00-04:00,PRGO,neutral
1032120.0,Perrigo Issues Response to 'Misleading Letter' from Mylan's Chair Coury,2015-09-10 07:56:00-04:00,PRGO,negative
1032121.0,"Benzinga's M&A Chatter for Tuesday September 8, 2015",2015-09-08 21:02:00-04:00,PRGO,neutral
1032122.0,Mylan Launch Offer FOr Perrigo Directly To Perrigo Shareholders on Sept. 14,2015-09-08 08:48:00-04:00,PRGO,neutral
1032123.0,"Benzinga's M&A Chatter for Monday August 31, 2015",2015-08-31 20:10:00-04:00,PRGO,neutral
1032124.0,"Perrigo Acquires ScarAway; Terms Not Disclosed, Expected TO Be Immediately Accretive To FY15 EPS",2015-08-31 08:34:00-04:00,PRGO,neutral
1032125.0,Benzinga's Weekend M&A Chatter,2015-08-30 20:30:00-04:00,PRGO,neutral
1032126.0,Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction,2015-08-28 08:05:00-04:00,PRGO,negative
1032127.0,Mylan Reports Holders Have 'Overwhelmingly' Approved Deal with Perrigo,2015-08-28 07:26:00-04:00,PRGO,positive
1032128.0,Irish Takeover Panel Says Perrigo's August 13 Statement 'Mylan Already Proposed a Dilutive Deal That Substantially Undervalues Perrigo' Violated Rule -Reuters,2015-08-25 11:11:00-04:00,PRGO,negative
1032129.0,Mylan Offers Clarification on Inaccuracies by Third Parties Related to Lowered Acceptance Condition for Purchase of Perrigo: Remains Fully Confident PRGO Holders Will See Value in Combo,2015-08-21 15:21:00-04:00,PRGO,positive
1032130.0,EU Commission Clears Acquisition of Certain GSK Consumer Health Assets by Perrigo -Reuters,2015-08-21 06:08:00-04:00,PRGO,positive
1032131.0,The Coming Drug-Patent Cliff Is Pushing This Portfolio Up,2015-08-20 14:48:00-04:00,PRGO,neutral
1032132.0,Benzinga's Top #PreMarket Losers,2015-08-17 08:18:00-04:00,PRGO,negative
1032133.0,Paulson & Co. Votes in Support of Mylan's Proposed Merger with Perrigo,2015-08-14 13:32:00-04:00,PRGO,positive
1032134.0,Perrigo +1% Following DJ Report on Paulson Stake,2015-08-14 11:57:00-04:00,PRGO,neutral
1032135.0,"Hedge Fund Paulson Buying Perrigo Shares, According to Sources -DJ",2015-08-14 11:50:00-04:00,PRGO,positive
1032136.0,ISS Affirms Perrigo's Position That Proposed Mylan Transaction Would Be Value Destructive,2015-08-14 11:08:00-04:00,PRGO,negative
1032137.0,"Mylan Responds to ISS Recommendation Regarding Perrigo Transaction, Confident Acquiring Perrigo Is Right Next Strategic Step",2015-08-14 09:21:00-04:00,PRGO,positive
1032138.0,"Benzinga's M&A Chatter for Thursday August 13, 2015",2015-08-13 19:01:00-04:00,PRGO,neutral
1032139.0,"UPDATE: Perrigo Says Tender Reduction 'Would further dilute an already dilutive transaction,' 'Would have significant negative impacts on ongoing operations'",2015-08-13 13:43:00-04:00,PRGO,negative
1032140.0,Perrigo Issues Comments on Mylan's 'Reckless' Lowering of Tender Threshold,2015-08-13 13:42:00-04:00,PRGO,negative
1032141.0,"Top Performing Industries For August 13, 2015",2015-08-13 10:46:00-04:00,PRGO,positive
1032142.0,Mylan Lowers Acceptace Condition On Perigo From Not Less Than 80% To Greater Than 50%,2015-08-13 07:08:00-04:00,PRGO,positive
1032143.0,Egan-Jones Sides With Glass Lewis In Recommending Mylan Shareholder To Vote For Perrigo Transaction Proposal,2015-08-12 14:11:00-04:00,PRGO,neutral
1032144.0,Mylan Announces Glass Lewis Has Recommended Co. Holders Vote for Perrigo Deal,2015-08-12 09:06:00-04:00,PRGO,positive
1032145.0,Mylan CEO Says Does Not Have to Have Perrigo; Looking at Other Targets,2015-08-06 10:36:00-04:00,PRGO,neutral
1032146.0,Perrigo Sees FY Adj EPS $7.50-$8.00 vs Est $7.64,2015-08-05 07:47:00-04:00,PRGO,neutral
1032147.0,"Perrigo Reports Q2 Adj. EPS $2.18 vs $1.96 Est., Sales $1.532B vs $1.52B Est.",2015-08-05 07:46:00-04:00,PRGO,neutral
1032148.0,"Earnings Scheduled For August 5, 2015",2015-08-05 04:56:00-04:00,PRGO,neutral
1032149.0,"Benzinga's M&A Chatter for Wednesday July 29, 2015",2015-07-29 20:06:00-04:00,PRGO,neutral
1032150.0,"RBC Says Stay Away From Mylan, Perrigo; Go Long Teva, Allergan",2015-07-29 08:54:00-04:00,PRGO,neutral
1032151.0,Mylan Receives Unconditional Clearance from EC on Acquisition of Perrigo,2015-07-29 07:10:00-04:00,PRGO,neutral
1032152.0,ETFs For The Next Pharma Takeover Candidates,2015-07-28 13:08:00-04:00,PRGO,neutral
1032153.0,"Teva Buys Allergan Unit: How Mylan, Other Biotech Stocks Are Reacting",2015-07-27 12:08:00-04:00,PRGO,neutral
1032154.0,Benzinga's Volume Movers,2015-07-27 10:23:00-04:00,PRGO,neutral
1032155.0,Morning Market Gainers,2015-07-27 09:39:00-04:00,PRGO,neutral
1032156.0,Teva Says Allergan Deal to have Fewer Antitrust Issues than Mylan Deal Would Have -Reuters,2015-07-27 08:36:00-04:00,PRGO,neutral
1032157.0,Benzinga's Top #PreMarket Gainers,2015-07-27 08:13:00-04:00,PRGO,positive
1032158.0,"Teva +10% Premarket, Mylan -13%; Perrigo +3%",2015-07-27 05:11:00-04:00,PRGO,neutral
1032159.0,Benzinga's Weekend M&A Chatter,2015-07-26 20:26:00-04:00,PRGO,neutral
1032160.0,"Perrigo Announces Will Purchase Yokebe, No Terms Disclosed",2015-07-22 07:12:00-04:00,PRGO,negative
1032161.0,"York Capital's James Dinan Mentions Healthcare Deals; Likes Mylan, Perrigo",2015-07-15 12:11:00-04:00,PRGO,positive
1032162.0,"Leerink Says Teva Likely to Raise Offer for Mylan, Says Sub $95/Share Offer Makes Sense for Teva; Mylan Could Ask for $100+ -Wall Street Journal",2015-07-07 08:53:00-04:00,PRGO,neutral
1032163.0,"Benzinga's M&A Chatter for Monday July 6, 2015",2015-07-06 18:10:00-04:00,PRGO,neutral
1032165.0,Top Takeaways From BMO's Specialty Pharma Day,2015-07-01 13:13:00-04:00,PRGO,positive
1032166.0,Hearing Mylan's CFO John Sheehan Has Said Co. Will Be Interested in Listing on the Tel Aviv Exchange if Perrigo Purchase Goes Through,2015-06-24 09:08:00-04:00,PRGO,positive
1032167.0,"Top Performing Industries For June 23, 2015",2015-06-23 10:41:00-04:00,PRGO,positive
1032168.0,Benzinga's Top Initiations,2015-06-23 09:26:00-04:00,PRGO,positive
1032169.0,BMO Capital Initiates Perrigo With Outperform,2015-06-23 08:50:00-04:00,PRGO,neutral
1032170.0,"Mylan to Discuss Possible Listing on Tel Aviv Stock Exchange Dependent on Acquiring Perrigo, According to Source -Reuters",2015-06-23 08:18:00-04:00,PRGO,neutral
1032171.0,"BMO Capital Initiates Coverage on Perrigo at Outperform, Announces $246.00 PT",2015-06-23 05:59:00-04:00,PRGO,neutral
1032172.0,"Worst Performing Industries For June 17, 2015",2015-06-17 11:45:00-04:00,PRGO,negative
1032173.0,"Top Performing Industries For June 16, 2015",2015-06-16 10:36:00-04:00,PRGO,positive
1032174.0,Mylan Offers Response to Abbott's Support for Perrigo Deal,2015-06-16 09:21:00-04:00,PRGO,positive
1032175.0,"Abbott Reports Affirmation of Support for Mylan as Standalone Strategy, Says Will Vote MYL Shares in Favor of Co.'s Proposed Deal with Perrigo",2015-06-16 09:01:00-04:00,PRGO,positive
1032176.0,"Worst Performing Industries For June 12, 2015",2015-06-12 11:55:00-04:00,PRGO,negative
1032177.0,"BTIG Research Initiates Coverage on Perrigo at Buy, Announces $223.00 PT",2015-06-03 17:58:00-04:00,PRGO,neutral
1032178.0,Analyst Knocks High-Profile Biotech Merger Battle; Opportunities Elsewhere,2015-06-03 17:05:00-04:00,PRGO,neutral
1032179.0,Raymond James Initiates Coverage on Perrigo at Market Perform,2015-06-03 06:33:00-04:00,PRGO,neutral
1032180.0,Perrigo to Acquire Portfolio of Leading OTC Brands from GSK,2015-06-02 06:34:00-04:00,PRGO,neutral
1032181.0,"Top Performing Industries For June 1, 2015",2015-06-01 11:05:00-04:00,PRGO,positive
1032182.0,Who's The Next Big Pharma Acquisition?,2015-05-29 11:20:00-04:00,PRGO,neutral
1032183.0,Report: Mylan Could See Sweetened Bid From Teva Pharmaceutical,2015-05-27 15:55:00-04:00,PRGO,neutral
1032184.0,"Mylan Asked By Irish Takeover Panel to Issue Clarification, Retraction In Accordance With Takeover Rules",2015-05-25 09:55:00-04:00,PRGO,neutral
1032185.0,Could M&A Boost Pfizer More? Jefferies Thinks So,2015-05-22 11:04:00-04:00,PRGO,positive
1032186.0,Option Alert: Perrigo Jun $210 Call; 2698 Contracts Traded vs 1950 OI; Now $197.88,2015-05-21 13:51:00-04:00,PRGO,positive
1032187.0,Hearing Perrigo Saying A Price Point Exists With Mylan That The Company Would Engage At,2015-05-18 12:05:00-04:00,PRGO,positive
1032188.0,Perrigo Shares Spike Higher on Volume,2015-05-18 12:05:00-04:00,PRGO,positive
1032189.0,Option Alert: Perrigo Jun $200 Call; 2200 Contract Trade at Ask @$6.00; Now $195,2015-05-18 10:02:00-04:00,PRGO,positive
1032190.0,Perrigo Acquires Patheon's Mexican Operations for $34M In Cash,2015-05-12 08:53:00-04:00,PRGO,neutral
1032191.0,Hearing Cowen & Co Saying Clients Should Aggressively Buy Shares At These Levels In Mylan and Teva,2015-05-11 14:39:00-04:00,PRGO,neutral
1032192.0,Analysts Met With UnitedHealth And Mylan Management; What Happened?,2015-05-11 10:08:00-04:00,PRGO,neutral
1032193.0,Report: Mylan Might See Higher Bid From Teva,2015-05-08 14:20:00-04:00,PRGO,neutral
1032194.0,Option Alert: Mylan Jun $75 Call; 1650 Contract Trade at Ask @$2.15,2015-05-08 12:40:00-04:00,PRGO,positive
1032195.0,Mylan Shares Spike Higher,2015-05-08 12:38:00-04:00,PRGO,positive
1032196.0,Horizon Pharma Announces Settlement of PENNSAID 2% Patent Litigation With Perrigo; Horizon Grants Perrigo Non-Exclusive Right to Market Generic Diclofenac Sodium Topical 2% W/W Solution in US,2015-05-08 06:05:00-04:00,PRGO,positive
1032197.0,"Jim Chanos, Kyle Bass Rip Oil And Pharma At SALT 2015",2015-05-07 17:39:00-04:00,PRGO,neutral
1032198.0,"SALT 2015: Top Investment Ideas From Bass, Burbank, Chanos & Cooperman",2015-05-07 17:22:00-04:00,PRGO,positive
1032199.0,Perrigo Spikes to High,2015-05-06 15:59:00-04:00,PRGO,neutral
1032200.0,Teva Says Expects All Necessary Antitrust Clearances for Mylan Acquisition Within 4-7 Months -Reuters,2015-05-05 12:45:00-04:00,PRGO,neutral
1032201.0,Analyst: Mylan Shareholders Might Get Convinced By Vigodman Letter,2015-04-30 16:25:00-04:00,PRGO,positive
1032202.0,"Benzinga's M&A Chatter for Wednesday April 29, 2015",2015-04-29 20:01:00-04:00,PRGO,neutral
1032203.0,Perrigo Release Confirms Rejection of Most-Recent Mylan Offer,2015-04-29 11:03:00-04:00,PRGO,negative
1032204.0,"David Faber @davidfaber Says: ""Perrigo to reject Mylan's latest offer. $PRGO using $55 as unaffected price. Believes this bid still below the $205 it originally rejected.""",2015-04-29 10:41:00-04:00,PRGO,negative
1032205.0,"Perrigo Company Expected To Reject Latest Mylan Offer, According to Source -Reuters",2015-04-29 10:06:00-04:00,PRGO,negative
1032206.0,"UPDATE: New Mylan Offer for Perrigo is $242.33/Share in Cash, Stock Based on Tuesday Closing Price",2015-04-29 09:28:00-04:00,PRGO,neutral
1032207.0,"Perrigo Shares Spike Over $210 Following News Mylan Ups Offer To Acquire Company, Mylan Shares Down Slightly",2015-04-29 09:24:00-04:00,PRGO,positive
1032208.0,"Mylan Announces raised Offer for Perrigo to $75/Share in Cash, 2.3 Shares of MYL",2015-04-29 09:21:00-04:00,PRGO,positive
1032209.0,"CNBC Currently Discussing Mylan, Perrigo; David Faber Reports Mylan Could Come Back with Another Offer for Perrigo",2015-04-28 09:43:00-04:00,PRGO,neutral
1032210.0,Hearing Cowen Says Teva Could Raise Bid for Mylan to $90/Share,2015-04-27 15:23:00-04:00,PRGO,neutral
1032211.0,"DAVID FABER @davidfaber Tweet: Mylan's response to Teva is one of the most condescending, sarcastic and nasty letters I've come across. Read it here bit.ly/1KnwFpe",2015-04-27 14:18:00-04:00,PRGO,negative
1032213.0,"Mylan Announces Board Has Unanimously Rejected Unsolicited Bid from Teva, Says Remains Committed to Firm Offer for Perrigo",2015-04-27 09:21:00-04:00,PRGO,negative
1032214.0,UBS Downgrades Perrigo to Neutral,2015-04-27 06:51:00-04:00,PRGO,neutral
1032215.0,B Riley Downgrades Perrigo to Neutral,2015-04-27 06:25:00-04:00,PRGO,neutral
1032216.0,Perrigrine Shares Fall 1.5% Following Downgrade at B Riley from Buy to Neutral,2015-04-27 06:24:00-04:00,PRGO,positive
1032217.0,Deutsche Bank Boosts Mylan's Price Target On This Scenario,2015-04-24 15:18:00-04:00,PRGO,positive
1032218.0,Release from Perrigo Confirms Co. Has Rejected Mylan Offer,2015-04-24 12:10:00-04:00,PRGO,negative
1032219.0,Hearing Perrigo Has Rejected Mylan Offer,2015-04-24 11:28:00-04:00,PRGO,negative
1032220.0,"Worst Performing Industries For April 24, 2015",2015-04-24 11:16:00-04:00,PRGO,negative
1032221.0,"Teva Spokesperson Says Teva Board, Management Team Remain Fully Committed to Completing Combination of Teva, Mylan -Reuters",2015-04-24 10:45:00-04:00,PRGO,positive
1032222.0,DAVID FABER @davidfaber Tweet:  Mylan stock certainly inflated due to $TEVA $82 bid for company (even if it has many obstacles). Hence PRGO not moving.,2015-04-24 10:13:00-04:00,PRGO,positive
1032223.0,UPDATE: Mylan Offer for Perrigo Boosted from $205/Share Previously to $60/Share in Cash + 2.2 MYL Shares ($73.69 as of Thursday's Close) = ~$222/Share,2015-04-24 09:51:00-04:00,PRGO,positive
1032224.0,"Mylan Announces Will Commence Formal Offer for Purchase of Perrigo at $60/Share in Cash, 2.2 MYL Shares",2015-04-24 09:45:00-04:00,PRGO,positive
1032225.0,"Benzinga's M&A Chatter for Wednesday April 22, 2015",2015-04-22 17:47:00-04:00,PRGO,neutral
1032226.0,Mylan Shares Spike to Low,2015-04-22 15:34:00-04:00,PRGO,neutral
1032227.0,Analyst Finds Perrigo 'Still Attractive' As Take Out Target,2015-04-22 11:59:00-04:00,PRGO,positive
1032228.0,What's Gabelli Saying About Teva Now?,2015-04-22 11:51:00-04:00,PRGO,neutral
1032229.0,"CNBC's David Faber Reporting He Expects Mylan to Come Out with a 'Firm' bid for Perrigo, Offer Will Include a Financing Committment",2015-04-22 09:44:00-04:00,PRGO,neutral
1032230.0,"CNBC Now @CNBCnow Tweet; : Mylan is planning a new offer for Perrigo in near term, sources tell @davidfaber.â¢ $MYL $PRGO",2015-04-22 09:43:00-04:00,PRGO,neutral
1032231.0,"Benzinga's M&A Chatter for Tuesday April 21, 2015",2015-04-21 19:37:00-04:00,PRGO,neutral
1032232.0,"Top Mylan Investors, including Paulson & Co, Encouraging Mylan Board to Consider Teva Offer, According to Sources -Reuters",2015-04-21 17:08:00-04:00,PRGO,positive
1032233.0,Perrigo Expecting FY Adj. EPS $7.50-$8 vs $7.29 Est.,2015-04-21 16:09:00-04:00,PRGO,neutral
1032234.0,"Perrigo Reports EPS $1.85 Vs Est $1.78, Sales $1.05B Vs Est $1.11B",2015-04-21 16:05:00-04:00,PRGO,neutral
1032235.0,"Perrigo Announces Board Has Unanimously Rejected Bid from Mylan, Calls Deal Undervalued",2015-04-21 16:03:00-04:00,PRGO,negative
1032236.0,"Perrigo Board Expected to Reject Mylan $29B Bid as Soon as This Week, According to Source -Reuters",2015-04-21 13:47:00-04:00,PRGO,negative
1032237.0,Stifel Nicolaus Downgrades Perrigo to Hold,2015-04-21 13:34:00-04:00,PRGO,neutral
1032238.0,Mylan Shares Jump On $40 Billion Bid From Teva Pharmaceutical,2015-04-21 10:52:00-04:00,PRGO,positive
1032239.0,Morning Market Losers,2015-04-21 09:57:00-04:00,PRGO,negative
1032240.0,"UPDATE: Teva Says Proposal  to Acquire Mylan Contingent on Mylan Not Completing Proposed Acquisition of Perrigo, Another Company",2015-04-21 08:53:00-04:00,PRGO,neutral
1032241.0,Benzinga's Top #PreMarket Losers,2015-04-21 08:23:00-04:00,PRGO,negative
1032242.0,UPDATE: Mylan Shares Rise 10% Following Report of Potential Teva Bid; Perrigo Shares Fall 4%,2015-04-21 07:18:00-04:00,PRGO,positive
1032243.0,Teva Spokesperson Declines Comment on Rumored Bid for Mylan -Reuters,2015-04-21 06:42:00-04:00,PRGO,neutral
1032244.0,Mylan Shares Rise 12% Premarket on Rumored Bid from Teva; Perrigo Shares Fall 4%,2015-04-21 06:36:00-04:00,PRGO,positive
1032245.0,Benzinga's Weekend M&A Chatter,2015-04-19 19:10:00-04:00,PRGO,neutral
1032246.0,Mylan: There's No Logic In The Teva Merger Rumor,2015-04-17 15:17:00-04:00,PRGO,negative
1032247.0,"Mylan Believes If An Actual Offer To Acquire Mylan Were To Materialize, The Board Would Carefully Consider The Option In Interest Of Stockholders, Company, And Stakeholders",2015-04-17 14:52:00-04:00,PRGO,positive
1032248.0,"Mylan Says That It Is Fully Commited To Stand Alone Strategy, Sees Much Overlap With Teva; Remains Committed On Proposal To Acquire Perrigo",2015-04-17 14:48:00-04:00,PRGO,neutral
1032249.0,Mylan Scores Final Win In Patent Challenge On Inhalation Drug,2015-04-17 14:27:00-04:00,PRGO,positive
1032250.0,UPDATE: Perrigo Shares Spike Lower on DJ Report of Teva Bid for Mylan,2015-04-17 14:22:00-04:00,PRGO,neutral
1032251.0,Perrigo Reports Final FDA Approval For Generic Version Of Kenalog Nasal Spray,2015-04-16 14:11:00-04:00,PRGO,positive
1032252.0,Why The Mylan 'Love Triangle' Could Benefit Investors,2015-04-13 13:43:00-04:00,PRGO,positive
1032253.0,"Top Performing Industries For April 13, 2015",2015-04-13 10:34:00-04:00,PRGO,positive
1032254.0,Argus Research Downgrades Perrigo to Hold,2015-04-10 08:21:00-04:00,PRGO,neutral
1032255.0,1 Challenge Bank Of America Sees For Mylan And Perrigo,2015-04-09 11:32:00-04:00,PRGO,positive
1032256.0,Hearing Renewed Takeover Chatter of Potential Pfizer Bid for Mylan,2015-04-09 09:44:00-04:00,PRGO,neutral
1032257.0,Citi Asks: Is A Mylan-Perrigo Merger Smart?,2015-04-09 09:36:00-04:00,PRGO,positive
1032258.0,And The Winner From The Mylan-Perrigo Merger Is... Teva?,2015-04-09 09:16:00-04:00,PRGO,positive
1032259.0,"Mylan Announcement under Irish Takeover Rules, Confirms Issued Share Capital of 489,503,828 Ordinary Shares",2015-04-09 08:50:00-04:00,PRGO,positive
1032260.0,"US Stock Futures Edge Lower Ahead Of Jobless Claims, Wholesale Inventories Data",2015-04-09 07:03:00-04:00,PRGO,negative
1032261.0,William Blair Downgrades Perrigo to Market Perform,2015-04-09 06:14:00-04:00,PRGO,neutral
1032262.0,Is Teva A Better Target For Mylan Than Perrigo? 2 Analysts Share Their Thoughts,2015-04-08 16:00:00-04:00,PRGO,positive
1032263.0,UPDATE: Perrigo Shareholders Would Recieve $205/Share In A Combination Of Cash & Mylan Stock For Each Perigo Stock; A 25% Premium To Perrigo's Closing Price Friday April 3rd.,2015-04-08 11:35:00-04:00,PRGO,neutral
1032264.0,UPDATE: Mylan Proposes to Acquire Perrigo for $205/Share,2015-04-08 11:30:00-04:00,PRGO,neutral
1032266.0,Mylan Proposes to Acquire Perrigo $205/Share,2015-04-08 11:29:00-04:00,PRGO,neutral
1032267.0,Perrigo Shares Halted on Volatility,2015-04-08 11:28:00-04:00,PRGO,positive
1032268.0,"Perrigo Announces FDA Approval, Upcoming Launch of AB Thearpeutics Equivalent to Exalgo",2015-04-08 08:54:00-04:00,PRGO,positive
1032269.0,Perrigo Company CEO On Completing The Omega Pharma Acquisition,2015-03-30 14:43:00-04:00,PRGO,neutral
1032270.0,Perrigo Completes Acquisition Of Omega Pharma,2015-03-30 10:48:00-04:00,PRGO,neutral
1032271.0,"Worst Performing Industries For March 23, 2015",2015-03-23 12:07:00-04:00,PRGO,negative
1032272.0,Benzinga's Top Downgrades,2015-03-23 08:42:00-04:00,PRGO,positive
1032273.0,RBC Capital Downgrades Perrigo To Sector Perform,2015-03-23 08:34:00-04:00,PRGO,neutral
1032274.0,US Stock Futures Edge Lower Ahead Of Existing-Home Sales Data,2015-03-23 07:45:00-04:00,PRGO,negative
1032275.0,"RBC Capital Downgrades Perrigo to Sector Perform, Lowers PT to $170.00",2015-03-23 06:46:00-04:00,PRGO,negative
1032276.0,"Worst Performing Industries For March 19, 2015",2015-03-19 11:16:00-04:00,PRGO,negative
1032277.0,"Top Performing Industries For March 16, 2015",2015-03-16 10:21:00-04:00,PRGO,positive
1032278.0,"Worst Performing Industries For March 3, 2015",2015-03-03 11:17:00-05:00,PRGO,negative
1032279.0,"From Perrigo Earnings Conference Call: Expecting Sales Growth in 5-9% Range, Had Previously Guided in 7-11% Range",2015-02-05 09:18:00-05:00,PRGO,positive
1032280.0,"Perrigo Reports Q2 Adj. EPS $1.82 vs $1.76 Est.,Sales $1.07B vs $1.09B Est; FY15 Adj. EPS $7.25-$7.45",2015-02-05 07:32:00-05:00,PRGO,neutral
1032281.0,"Earnings Scheduled For February 5, 2015",2015-02-05 05:05:00-05:00,PRGO,neutral
1032282.0,"S&P 500 Stocks With Most Active Options Today: PRGO, HCBK, SJM, FAST, LRCX",2015-02-04 15:31:00-05:00,PRGO,positive
1032283.0,"Worst Performing Industries For January 22, 2015",2015-01-22 11:22:00-05:00,PRGO,negative
1032284.0,4 Stocks Trending On Social Media This Monday,2015-01-12 09:38:00-05:00,PRGO,neutral
1032285.0,Perrigo Launches AB Therapeutic Equivalent Testosterone Gel 1.0%,2015-01-12 08:28:00-05:00,PRGO,neutral
1032286.0,Perrigo Partners With Ferrara Candy Company; Enters $625M Gummy Vitamins And Dietary Supplement Market,2015-01-12 08:27:00-05:00,PRGO,neutral
1032287.0,Perrigo Launches The Generic Version Of Clobex,2015-01-12 08:23:00-05:00,PRGO,neutral
1032288.0,"#PreMarket Primer: Wednesday, December 31: Officials Closer To An Answer On AirAsia Jet Crash",2014-12-31 08:22:00-05:00,PRGO,negative
1032289.0,"Worst Performing Industries For December 23, 2014",2014-12-23 11:25:00-05:00,PRGO,negative
1032290.0,UPDATE: Launch Of The Generic Version Of Pennsaid,2014-12-02 08:50:00-05:00,PRGO,neutral
1032291.0,FDA Approves Perrigo's Launch Of The Generic Version Of Pennsaid,2014-12-02 08:49:00-05:00,PRGO,positive
1032292.0,Perrigo Company Press Release Confirms $1.6B Senior Notes Offering,2014-11-24 16:45:00-05:00,PRGO,neutral
1032293.0,Perrigo To Offer $500M 7-year Notes; $700M 10-year Notes; $400M 30-year Bonds,2014-11-24 15:48:00-05:00,PRGO,neutral
1032294.0,"Top Performing Industries For November 24, 2014",2014-11-24 10:35:00-05:00,PRGO,positive
1032295.0,Perrigo Company's Perrigo Finance plc Announces Proposed Offering Of Senior Notes,2014-11-24 08:48:00-05:00,PRGO,neutral
1032296.0,"CRT Capital Reiterates Buy on Perrigo Company, Raises PT to $184.00",2014-11-24 08:40:00-05:00,PRGO,neutral
1032297.0,Perrigo Reports Confirmation to File Patent Challenge for Generic Version of Aveed Injection,2014-11-24 07:56:00-05:00,PRGO,positive
1032298.0,"7-Eleven Has Unveiled Private Label Drug Business, Partnering with Perrigo",2014-11-18 09:37:00-05:00,PRGO,neutral
1032299.0,Perrigo Acquires Omega Pharma For $4.5 Billion Euro,2014-11-06 11:28:00-05:00,PRGO,neutral
1032300.0,Perrigo Company Sees FY2015 EPS $7.20-7.50,2014-11-06 06:41:00-05:00,PRGO,neutral
1032301.0,Perrigo Company Reports Q1 EPS of $1.40 vs $1.44 Est; Revenue of $951.50M vs $997.90M Est,2014-11-06 06:36:00-05:00,PRGO,neutral
1032302.0,Perrigo To Buy Omega Pharma For E$3.6B Including E$1.1B,2014-11-06 06:28:00-05:00,PRGO,neutral
1032303.0,"Earnings Scheduled For November 6, 2014",2014-11-06 05:42:00-05:00,PRGO,neutral
1032304.0,"Benzinga's M&A Chatter for Thursday October 30, 2014",2014-10-30 21:24:00-04:00,PRGO,neutral
1032305.0,Markets Rally On Better Than Expected GDP; Dow Has Best Close In More Than A Month,2014-10-30 17:09:00-04:00,PRGO,positive
1032306.0,Perrigo Surges Amid Report Of Omega Pharma Acquisition,2014-10-30 11:17:00-04:00,PRGO,neutral
1032307.0,"Top Performing Industries For October 30, 2014",2014-10-30 11:10:00-04:00,PRGO,positive
1032308.0,Perrigo Rumored to be in Exclusive Talks to Purchase Omega Pharma,2014-10-30 09:16:00-04:00,PRGO,positive
1032309.0,"Benzinga's M&A Chatter for Monday October 20, 2014",2014-10-20 19:27:00-04:00,PRGO,neutral
1032310.0,UPDATE: Omega Pharma Valued at â¬4B,2014-10-20 17:17:00-04:00,PRGO,positive
1032311.0,"Actavis May Have Joined Bidding for Omega Pharma, Sanofi, Perrigo, Boehringer Also Considering Offer",2014-10-20 17:15:00-04:00,PRGO,neutral
1032312.0,"Perrigo Reports Out-Licensing of Preclinical Assets to Imago Pharma, Co. Will Receive Undisclosed Upfront Payment",2014-09-29 07:43:00-04:00,PRGO,positive
1032313.0,Perrigo Reports Purchase of Women's Health Product Portfolio from Lumara for $82M; Deal Will Add to ROIC in FY16,2014-09-29 07:10:00-04:00,PRGO,neutral
1032314.0,"#PreMarket Primer: Wednesday, September 10: Dollar General Gets Aggressive",2014-09-10 07:38:00-04:00,PRGO,negative
1032315.0,"UPDATE: Omega Pharma Interest Rumor Coming from Bloomberg, Headline Also Suggests Boehringer Could Be Interested in Co.",2014-08-28 12:46:00-04:00,PRGO,positive
1032316.0,Perrigo Shares Volatile on Report it is Interested in Omega Pharma,2014-08-28 12:44:00-04:00,PRGO,positive
1032317.0,Benzinga's Top #PreMarket Losers,2014-08-18 08:20:00-04:00,PRGO,negative
1032318.0,"Markets Gather Some Momentum As Volume Remains Light, Geopolitical Tension Improving",2014-08-14 16:37:00-04:00,PRGO,positive
1032319.0,"Top Performing Industries For August 14, 2014",2014-08-14 10:24:00-04:00,PRGO,positive
1032320.0,Perrigo Company Sees FY2015 EPS $7.20-7.50 vs $7.53 Est,2014-08-14 07:53:00-04:00,PRGO,neutral
1032321.0,Perrigo Company Reports Q4 EPS of $1.74 vs $1.55 Est; Revenue of $1.14B vs $1.09B Est,2014-08-14 07:52:00-04:00,PRGO,neutral
1032322.0,"Earnings Scheduled For August 14, 2014",2014-08-14 05:56:00-04:00,PRGO,neutral
1032323.0,5 Companies That Have Moved Overseas For Lower Taxes,2014-08-12 10:06:00-04:00,PRGO,negative
1032324.0,Benzinga Weekly Preview: US Airstrikes Likely To Wreak Havoc on Markets,2014-08-10 17:39:00-04:00,PRGO,negative
1032325.0,"Worst Performing Industries For August 6, 2014",2014-08-06 11:08:00-04:00,PRGO,negative
1032326.0,"#PreMarket Primer: Wednesday, August 6: Sprint Prepares To Go It Alone",2014-08-06 07:17:00-04:00,PRGO,negative
1032327.0,Perrigo Announces Patent Suit Against Generic Version Created By Taro Pharma,2014-07-30 08:11:00-04:00,PRGO,positive
1032328.0,Perrigo Confirms The FDA Has Ruled It's Testosterone Gel Equivalent to AbbVie's AndroGel,2014-07-24 12:57:00-04:00,PRGO,neutral
1032329.0,Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0%,2014-07-24 12:56:00-04:00,PRGO,neutral
1032330.0,"#PreMarket Primer: Tuesday, July 22: Separatists Hand Over Remains From Malaysian Airlines Flight",2014-07-22 07:11:00-04:00,PRGO,positive
1032331.0,Hearing Deal Reporter Says Perrigo has Not been Approached About Sale,2014-07-18 09:34:00-04:00,PRGO,neutral
1032332.0,Perrigo Down 3% On Sale Rumor,2014-07-15 16:19:00-04:00,PRGO,neutral
1032333.0,UPDATE: Perrigo Declines Comment on Monday's Rumor of a Potential Sale,2014-07-15 11:08:00-04:00,PRGO,neutral
1032334.0,"Worst Performing Industries For July 15, 2014",2014-07-15 11:02:00-04:00,PRGO,negative
1032335.0,"Benzinga's M&A Chatter for Monday July 14, 2014",2014-07-14 18:30:00-04:00,PRGO,neutral
1032336.0,Perrigo Rumored To Be On Block; 'Market Source' Sees 25% Premium,2014-07-14 12:06:00-04:00,PRGO,negative
1032337.0,"Worst Performing Industries For July 14, 2014",2014-07-14 10:38:00-04:00,PRGO,negative
1032338.0,Globes Reports Perrigo Hires Investment Bank to Explore Sale,2014-07-14 10:37:00-04:00,PRGO,neutral
1032339.0,Perrigo Spikes Higher,2014-07-14 10:36:00-04:00,PRGO,neutral
1032340.0,Shares of Perrigo Lower Following Downgrade from Morgan Stanley,2014-07-11 09:42:00-04:00,PRGO,neutral
1032341.0,Perrigo Announces FDA's Final Approval for Store Brand Equivalent of Advil for Congestion Relief,2014-07-08 08:50:00-04:00,PRGO,positive
1032342.0,"#PreMarket Primer: Monday, June 30: U.S. Data To Confirm Second Quarter Recovery",2014-06-30 06:50:00-04:00,PRGO,neutral
1032343.0,Perrigo Issues Release Confirming Settlement with Teva Related to Proair HFA Patent Case,2014-06-20 09:20:00-04:00,PRGO,neutral
1032344.0,"Teva Reaches Settlement Regarding ProAir, Perrigo and Catalent to Receive License for Limited Units, Other Terms Not Disclosed",2014-06-20 09:01:00-04:00,PRGO,negative
1032345.0,"Top Performing Industries For June 2, 2014",2014-06-02 10:45:00-04:00,PRGO,positive
1032346.0,UPDATE: Perrigo Announces FDA Approval for Generic Version of Astepro,2014-05-12 09:25:00-04:00,PRGO,positive
1032347.0,Perrigo Announces FDA Approval for Generic Version of Astepro,2014-05-12 09:23:00-04:00,PRGO,positive
1032348.0,"Earlier Buckingham Research Downgraded Perrigo Company to Neutral, Lowered PT to $140.00",2014-05-08 10:11:00-04:00,PRGO,negative
1032349.0,"RBC Capital Downgraded Perrigo Company to Outperform, Lowered PT to $160.00 On Disappointing Earnings Report",2014-05-08 10:04:00-04:00,PRGO,negative
1032350.0,"Morgan Stanley Maintains Overweight on Perrigo Company, Lowers PT to $152.00",2014-05-08 07:07:00-04:00,PRGO,negative
1032351.0,"From Perrigo's Earnings Conf. Call: Expecting FY14 Sales Growth 13-15%, Had Previously Guided in the 15-18% Growth Range",2014-05-07 10:26:00-04:00,PRGO,positive
1032352.0,Stocks Hitting 52-Week Lows,2014-05-07 10:24:00-04:00,PRGO,negative
1032353.0,Perrigo Company Lowers FY2014 EPS Guidance from $6.45-6.70 to $6.15-6.30 vs $6.61 Est,2014-05-07 08:03:00-04:00,PRGO,negative
1032354.0,Perrigo Company Reports Q3 EPS of $1.31 vs $1.51 Est; Revenue of $1.0B vs $1.07B Est,2014-05-07 08:01:00-04:00,PRGO,neutral
1032355.0,"Earnings Scheduled For May 7, 2014",2014-05-07 05:15:00-04:00,PRGO,neutral
1032356.0,"Jefferies Initiates Coverage on Perrigo Company at Buy, Announces $180.00 PT",2014-04-21 16:25:00-04:00,PRGO,neutral
1032357.0,"#PreMarket Primer: Monday, April 7: World Bank Lowers China's 2014 Growth Forecast",2014-04-07 06:59:00-04:00,PRGO,positive
1032358.0,5 Healthcare Stocks With The Highest EPS,2014-04-01 09:55:00-04:00,PRGO,neutral
1032359.0,Perrigo Announces Launch Of Authorized Generic Version Of Taclonex Ointment,2014-04-01 08:17:00-04:00,PRGO,neutral
1032360.0,"#PreMarket Primer: Tuesday, March 25: Group Of Seven Calls For Tougher Sanctions",2014-03-25 07:10:00-04:00,PRGO,positive
1032361.0,"#PreMarket Primer: Monday, March 24: NATO Commander Warns Russia Could Be Eyeing Another Takeover ",2014-03-24 06:39:00-04:00,PRGO,negative
1032362.0,Perrigo Unveils Generic Version of Neptazane Tablets,2014-03-12 08:43:00-04:00,PRGO,neutral
1032363.0,#PreMarket Primer: Monday March 10: Russia Tightens Its Grip On Crimea,2014-03-10 07:31:00-04:00,PRGO,neutral
1032364.0,UPDATE: Morgan Stanley Reiterates On Perrigo Company Following Solid Analyst Day,2014-03-03 09:39:00-05:00,PRGO,positive
1032365.0,"Stifel Nicolaus Maintains Buy on Perrigo Company, Raises PT to $175.00",2014-03-03 08:52:00-05:00,PRGO,neutral
1032366.0,Transition Therapeutics Announces $15M Investment by Perrigo,2014-02-28 07:30:00-05:00,PRGO,neutral
1032367.0,Perrigo Buys Products from Aspen Global for $51M,2014-02-28 07:14:00-05:00,PRGO,neutral
1032368.0,"#PreMarket Primer: Wednesday, February 26: Bitcoin Faces Another Major Setback",2014-02-26 07:18:00-05:00,PRGO,neutral
1032369.0,Perrigo Shares Edge Lower Following Earlier Downgrade from B. Riley & Co.,2014-02-07 09:59:00-05:00,PRGO,neutral
1032370.0,UPDATE: Perrigo Sales Growth Guidance on Call Was Reaffirmed from Last-Given Outlook,2014-02-06 10:54:00-05:00,PRGO,positive
1032371.0,"From Perrigo Call: Sales Growth Expected in 15-18% Range, Adj. Gross Margin in 41-43% Range",2014-02-06 10:52:00-05:00,PRGO,negative
1032372.0,Perrigo Company Narrows FY2014 Adj. EPS Guidance from $6.35-6.60 to $6.45-0.70 vs $6.63 Est,2014-02-06 08:09:00-05:00,PRGO,neutral
1032373.0,Perrigo Raises FY14 GAAP EPS Outlook to $2.45-2.70,2014-02-06 08:05:00-05:00,PRGO,neutral
1032374.0,Perrigo Company Reports Q2 EPS of $1.87 vs $1.59 Est; Revenue of $979.0M vs $996.68M Est,2014-02-06 08:03:00-05:00,PRGO,neutral
1032375.0,"Earnings Scheduled For February 6, 2014",2014-02-06 04:29:00-05:00,PRGO,neutral
1032376.0,Perrigo Raises Qtr. Dividend from $0.09 to $0.105/Share,2014-01-29 11:21:00-05:00,PRGO,neutral
1032377.0,Prothena Announces Pricing of Secondary Offering by Perrigo at $26/Share,2014-01-29 08:09:00-05:00,PRGO,neutral
1032378.0,"#PreMarket Primer: Monday, January 27: Markets Open The Week On Edge",2014-01-27 07:16:00-05:00,PRGO,neutral
1032379.0,Perrigo Receives FDA Final Approval For Generic Equivalent To Prandin,2014-01-24 07:51:00-05:00,PRGO,positive
1032380.0,UPDATE: Bank of America Upgrades Perrigo,2014-01-07 09:07:00-05:00,PRGO,neutral
1032381.0,Bank of America Upgrades Perrigo Company to Buy,2014-01-07 06:50:00-05:00,PRGO,neutral
1032382.0,"RBC Capital Initiates Coverage on Perrigo Company at Top Pick, Announces $187.00 PT",2014-01-06 17:15:00-05:00,PRGO,positive
1032383.0,#PreMarket Primer For December 31: Last Day Of Trading For 2013,2013-12-31 06:36:00-05:00,PRGO,neutral
1032384.0,"#PreMarket Primer for December 30: Blackstone Invests In Crocs, Google & Apple Enter Auto Industry",2013-12-30 06:54:00-05:00,PRGO,neutral
1032385.0,Benzinga's Top #PreMarket Losers,2013-12-26 08:21:00-05:00,PRGO,negative
1032386.0,"#PreMarket Primer: Thursday, December 26: Nikkei Climbs To New Highs",2013-12-26 07:06:00-05:00,PRGO,neutral
1032387.0,S&P Upgrades Elan Corp. plc from B+ to BBB; Outlook Stable,2013-12-19 16:22:00-05:00,PRGO,positive
1032388.0,"Morgan Stanley Reinstates Overweight on Perrigo Company, Announces $183.00 PT",2013-12-19 06:40:00-05:00,PRGO,negative
1032389.0,"#PreMarket Primer: Tuesday, December 17: US Markets Rebound Overnight",2013-12-17 06:47:00-05:00,PRGO,neutral
1032390.0,Perrigo CEO Papa: 'Our Board Meetings Will be Held in Irleand',2013-12-16 18:21:00-05:00,PRGO,neutral
1032391.0,Perrigo CEO Papa: 'Pet Care is Important to Retailers',2013-12-16 18:19:00-05:00,PRGO,positive
1032392.0,Perrigo CEO Papa: 'Retailers are Giving Us More Space than Ever',2013-12-16 18:19:00-05:00,PRGO,positive
1032393.0,Jim Cramer Interviews CEO Joe Papa  of Perrigo on Mad Money,2013-12-16 18:18:00-05:00,PRGO,negative
1032394.0,"Perrigo, Elan Receive Irish High Court Approval for Perrigo's Proposed Acquisition of Elan ",2013-12-13 07:59:00-05:00,PRGO,positive
1032395.0,UPDATE: Stifel Raises PT on Perrigo Company on Attractive Long-Term Growth Prospects,2013-12-12 11:13:00-05:00,PRGO,positive
1032396.0,"Stifel Nicolaus Maintains Buy on Perrigo Company, Raises PT to $165.00",2013-12-12 09:11:00-05:00,PRGO,neutral
1032397.0,#PreMarket Primer for December 11: US Government Takes First Steps Towards Budget Deal,2013-12-11 06:43:00-05:00,PRGO,neutral
1032398.0,"#PreMarket Primer: Monday, December, 2: Thousands Of Protesters Gather In Kiev",2013-12-02 07:01:00-05:00,PRGO,negative
1032399.0,Top 4 Stocks In The Drug Related Products Industry With The Highest EPS Estimates,2013-11-29 04:19:00-05:00,PRGO,positive
1032400.0,Perrigo Confirms Filing ANDA with FDA For Generic Acanya ,2013-11-20 11:25:00-05:00,PRGO,neutral
1032401.0,"#PreMarket Primer: Tuesday, November 19: Putin Optimistic About Iranian Deal",2013-11-19 06:49:00-05:00,PRGO,positive
1032402.0,Perrigo Shareholders Approve Acquisition Of Elan ,2013-11-18 15:36:00-05:00,PRGO,neutral
1032403.0,"13F from SAC Capital Shows Liquidated Stakes in Gold Miners ETF, PetSmart, New Stakes in Zynga, Nokia, Perrigo, Panera",2013-11-14 14:03:00-05:00,PRGO,neutral
1032404.0,"Perrigo Reports Commencement of Voluntary Product Recall of Acetaminophen Infant Suspension Liquid, Says Sees No Material Effect on Outlook",2013-11-01 15:20:00-04:00,PRGO,negative
1032405.0,"Perrigo Call Underway, Exec Says Still Expecting FY14 Sales Growth 12-16% YoY, Adj. Gross Margin in 38-42% Range",2013-10-31 11:11:00-04:00,PRGO,negative
1032406.0,Perrigo Company Reports Q1 EPS of $1.52 vs $1.40 Est; Revenue of $933.0M vs $900.10M Est,2013-10-31 07:43:00-04:00,PRGO,neutral
1032407.0,"Earnings Scheduled For October 31, 2013",2013-10-31 05:03:00-04:00,PRGO,neutral
1032408.0,"Market Primer: Thursday, October 24: Investors Switch Focus To Earnings",2013-10-24 06:43:00-04:00,PRGO,neutral
1032409.0,"Market Primer: Tuesday, October 8: US Treasury Yields Climb As Markets Succumb To Default Fears",2013-10-08 06:34:00-04:00,PRGO,negative
1032410.0,"Market Primer: Thursday, October 3: Third Day Of US Government Halt Drags On The Dollar",2013-10-03 06:47:00-04:00,PRGO,negative
1032411.0,Pharmaceutical Industry Expected To Collect Billions From Obamacare,2013-10-02 12:51:00-04:00,PRGO,neutral
1032412.0,UPDATE: Perrigo Wins FDA Approval for Generic Version of Nitrolingual Spray,2013-09-23 09:05:00-04:00,PRGO,positive
1032413.0,Perrigo Wins FDA Approval for Generic Version of Nitrolingual Spray,2013-09-23 09:05:00-04:00,PRGO,positive
1032414.0,"Market Primer: Monday, September 23: Merkel Victorious, Coalition Was Not So Lucky",2013-09-23 06:46:00-04:00,PRGO,negative
1032415.0,"CRT Capital Initiates Coverage on Perrigo Company at Buy, Announces $145.00 PT",2013-09-17 09:16:00-04:00,PRGO,neutral
1032416.0,Perrigo Reports FDA Final Approval for Generic of Children's Zyrtec Syrup,2013-09-10 09:29:00-04:00,PRGO,positive
1032417.0,"Benzinga Market Primer: Monday, September 9: Futures Up As Japan Starts The Week Off With A Bang      ",2013-09-09 06:29:00-04:00,PRGO,neutral
1032418.0,Benzinga's Top Pre-Market Losers ,2013-08-16 08:17:00-04:00,PRGO,negative
1032419.0,"Benzinga Market Primer Friday, August 16",2013-08-16 06:48:00-04:00,PRGO,neutral
1032420.0, Perrigo CEO Papa: ' Demand for Infant Formula Made in US in China is Astronomical',2013-08-15 18:21:00-04:00,PRGO,negative
1032421.0, Perrigo CEO Papa: 'We Expect to Launch More than 75 New Products this Year',2013-08-15 18:19:00-04:00,PRGO,neutral
1032422.0, Perrigo CEO Papa: 'Elan Enables Our Global Growth and Acquisition Strategy',2013-08-15 18:17:00-04:00,PRGO,positive
1032423.0,Jim Cramer Interviews CEO Joseph C. Papa of Perrigo on Mad Money,2013-08-15 18:16:00-04:00,PRGO,negative
1032424.0,From Perrigo Call: Expecting FY14 Sales Growth 12-16%,2013-08-15 10:05:00-04:00,PRGO,positive
1032425.0,Perrigo Company Sees FY2014 EPS $6.35-6.60 vs $6.67 Est,2013-08-15 08:18:00-04:00,PRGO,neutral
1032426.0,Perrigo Company Reports Q4 EPS of $1.57 vs $1.56 Est; Revenue of $967.0M vs $1.0B Est,2013-08-15 08:18:00-04:00,PRGO,neutral
1032427.0,"Benzinga Market Primer: Thursday, August 15: Futures Lower After Cisco Earnings, Weaker Dollar",2013-08-15 06:37:00-04:00,PRGO,negative
1032428.0,"Earnings Scheduled For August 15, 2013",2013-08-15 04:32:00-04:00,PRGO,neutral
1032429.0,Perrigo Company Announces FDA Final Approvals For The Generic Equivalents To Derma-Smoothe/FSÂ® Scalp Oil And Body Oil ,2013-08-12 09:15:00-04:00,PRGO,neutral
1032430.0,"Teva, Perrigo Reports US Launch of Generic Temozolomide",2013-08-12 08:33:00-04:00,PRGO,neutral
1032431.0,Earnings Expectations For The Week Of August 12,2013-08-11 13:01:00-04:00,PRGO,neutral
1032432.0,Top 4 Stocks In The Drug Related Products Industry With The Lowest PEG Ratio,2013-08-01 04:21:00-04:00,PRGO,negative
1032433.0,UPDATE: Deutsche Bank Upgrades Perrigo Following Elan Acquisition Announcement,2013-07-30 11:33:00-04:00,PRGO,neutral
1032434.0,UPDATE: Stifel Nicolaus Raises PT on Perrigo Following Elan Acquisition,2013-07-30 11:28:00-04:00,PRGO,neutral
1032435.0,"Deutsche Bank Upgrades Perrigo Company to Buy, Raises PT to $150.00",2013-07-30 10:04:00-04:00,PRGO,neutral
1032436.0,Deutsche Bank Upgraded Perrigo from Hold to Buy,2013-07-30 09:33:00-04:00,PRGO,neutral
1032437.0,"Stifel Nicolaus Maintains Buy on Perrigo Company, Raises undefined to $145.00",2013-07-30 09:08:00-04:00,PRGO,neutral
1032438.0,UPDATE: Goldman Sachs Upgrades Perrigo on Multiple Positive Factors,2013-07-30 08:43:00-04:00,PRGO,positive
1032439.0,Benzinga's Top Upgrades,2013-07-30 07:56:00-04:00,PRGO,positive
1032440.0,"Goldman Sachs Upgrades Perrigo Company to Neutral, Raises PT to $132.00",2013-07-30 06:52:00-04:00,PRGO,neutral
1032441.0,"Benzinga's M&A Chatter for Monday July 29, 2013",2013-07-29 17:32:00-04:00,PRGO,neutral
1032442.0,UPDATE: Bank of America Upgrades Perrigo on Financial Engineering Deal Adding Value,2013-07-29 17:16:00-04:00,PRGO,positive
1032443.0,"Market Wrap for Monday, July 29: Stocks Record Moderate Losses to Start Trading Week",2013-07-29 16:23:00-04:00,PRGO,negative
1032444.0,Mid-Afternoon Market Update: Turqoise Hill Resources Falls as CF Industries Shoots Upwards Following Loeb Stake,2013-07-29 15:54:00-04:00,PRGO,neutral
1032445.0,Bank of America Upgrades Perrigo Company to Neutral,2013-07-29 14:49:00-04:00,PRGO,neutral
1032446.0,Perrigo Outlook Cut to Negative From Stable By S&P Following Elan Acquisition ,2013-07-29 13:24:00-04:00,PRGO,negative
1032447.0,"Mid-Day Market Update: Saks Rises On Acquisition News, Sohu Shares Drop",2013-07-29 12:44:00-04:00,PRGO,neutral
1032448.0,"The Top 10 Financial Tweets For Monday, July 29",2013-07-29 11:08:00-04:00,PRGO,positive
1032449.0,Stocks Hitting 52-Week Highs,2013-07-29 10:17:00-04:00,PRGO,neutral
1032450.0,"Mid-Morning Market Update: Markets Open Lower, Perrigo To Acquire Elan For $8.6B",2013-07-29 10:15:00-04:00,PRGO,negative
1032451.0,"Merger Monday Strikes Again (OMC, SKS, PRGO, ELN)",2013-07-29 09:28:00-04:00,PRGO,negative
1032452.0,Benzinga's Top Pre-Market Gainers,2013-07-29 08:13:00-04:00,PRGO,positive
1032453.0,FDA Issues Review of Proposed OTC USage of Sanofi's Nasacort Spray,2013-07-29 08:06:00-04:00,PRGO,neutral
1032454.0,A Peek Into The Market Before The Trading Starts,2013-07-29 07:27:00-04:00,PRGO,neutral
1032455.0,"Benzinga Market Primer: Monday, July 29: Futures Lower On Chinese Fears",2013-07-29 06:55:00-04:00,PRGO,negative
1032456.0,"Perrigo to Acquire Elan for $8.6 Billion in Cash, Stock Deal",2013-07-29 05:51:00-04:00,PRGO,neutral
1032457.0,Perrigo Reportedly Near Deal to Acquire Elan -Bloomberg,2013-07-28 20:16:00-04:00,PRGO,neutral
1032458.0,"Leerink's Gerberry Speculating on Possible Elan, Perrigo Deal, Says Terms Would Need to Be 50% Debt/50% Equity, Sees Elan Takeover ~$17/Share",2013-07-25 12:24:00-04:00,PRGO,neutral
1032459.0,"Benzinga's M&A Chatter for Wednesday July 24, 2013",2013-07-24 17:49:00-04:00,PRGO,neutral
1032460.0,"Reuters Reporting Perrigo, Forest Labs Prepping Bid for Elan ",2013-07-24 16:37:00-04:00,PRGO,neutral
1032461.0,Perrigo Receives FDA Tentative Approval For Generic Equivalent To Prandin(R) ,2013-07-19 08:16:00-04:00,PRGO,positive
1032462.0,UPDATE: Canaccord Genuity Raises PT on Perrigo on Attractive Medium-Term Opportunities,2013-07-09 15:03:00-04:00,PRGO,positive
1032463.0,ETF Showdown: Israel in The Spotlight,2013-06-26 15:06:00-04:00,PRGO,neutral
1032464.0,Top 4 Stocks In The Drug Related Products Industry With The Highest ROA,2013-06-21 04:22:00-04:00,PRGO,positive
1032465.0,"Jefferies Says Analysis on Elan Supports $19/Share Takeover Bid, Lifts Price Target to $19",2013-06-18 10:39:00-04:00,PRGO,positive
1032466.0,UPDATE: Deutsche Bank Raises PT on Perrigo Following Fera Pharmaceuticals Agreement Announcement,2013-06-18 10:37:00-04:00,PRGO,positive
1032467.0,"Deutsche Bank Maintains Hold on Perrigo Company, Raises PT to $120.00",2013-06-18 07:57:00-04:00,PRGO,neutral
1032468.0,"Morgan Stanley Initiates Coverage on Perrigo Company at Overweight, Announces $133.00 PT",2013-06-12 08:02:00-04:00,PRGO,negative
1032469.0,Benzinga's Top Pre-Market Gainers,2013-06-10 08:20:00-04:00,PRGO,positive
1032470.0,"Netflix. to Join NASDAQ-100 Index on June 6, 2013 ",2013-05-31 05:59:00-04:00,PRGO,positive
1032471.0,Perrigo Receives Final Approval from FDA for Generic Version of Sanctura XR,2013-05-29 07:55:00-04:00,PRGO,positive
1032472.0,Perrigo CEO Papa: 'We Got into Pet Care to Give Consumers a Quality Product',2013-05-09 18:31:00-04:00,PRGO,positive
1032473.0,Perrigo CEO Papa: 'Consumers Realize we Meet the Same FDA Requirements as National Brands and Give them a 25% Discount',2013-05-09 18:30:00-04:00,PRGO,neutral
1032474.0,"Perrigo CEO Papa: 'In Our Largest Business, Consumer Healthcare, We had 20% Growth'",2013-05-09 18:29:00-04:00,PRGO,positive
1032475.0,Jim Cramer Interviews CEO Joseph C. Papa of Perrigo on Mad Money,2013-05-09 18:21:00-04:00,PRGO,negative
1032476.0,"Morgan Stanley Maintains Overweight on Perrigo Company, Raises PT to $133.00",2013-05-07 15:47:00-04:00,PRGO,negative
1032477.0,Perrigo Files Automatic Debt Securities Shelf,2013-05-07 09:44:00-04:00,PRGO,negative
1032478.0,Perrigo Company Reports Q3 EPS of $1.42 vs $1.44 Est,2013-05-07 07:45:00-04:00,PRGO,neutral
1032479.0,US Stock Futures Up Ahead Of Consumer Credit Data,2013-05-07 06:40:00-04:00,PRGO,positive
1032480.0,"Earnings Scheduled For May 7, 2013",2013-05-07 04:13:00-04:00,PRGO,neutral
1032481.0,"The Week Ahead: Host of Earnings on Tap; Investors Watching Anadarko, Activision, and Whole Foods",2013-05-03 18:43:00-04:00,PRGO,neutral
1032482.0,Benzinga's Top Initiations,2013-04-24 07:58:00-04:00,PRGO,positive
1032483.0,Leerink Swann Initiates Coverage on Perrigo Company at Market Perform,2013-04-24 07:53:00-04:00,PRGO,neutral
1032484.0,UPDATE: J.P. Morgan Upgrades Perrigo Company to Overweight on Diversified Growth Drivers,2013-04-22 09:06:00-04:00,PRGO,neutral
1032485.0,Benzinga's Top Upgrades,2013-04-22 07:24:00-04:00,PRGO,positive
1032486.0,"JP Morgan Upgrades Perrigo Company to Overweight, Raises PT to $132.00",2013-04-22 06:16:00-04:00,PRGO,neutral
1032487.0,"Golden Crosses Over The Past Trading Week (50 SMA Cross Above 200 SMA) CMG, LO, MRK, PRGO, SO, WMT, YUM",2013-04-08 13:28:00-04:00,PRGO,neutral
1032489.0,"JP Morgan Maintains Neutral on Perrigo Company, Raises PT to $120.00",2013-04-03 08:58:00-04:00,PRGO,positive
1032490.0,Perrigo Closes Purchase of Velcera,2013-04-01 09:18:00-04:00,PRGO,neutral
1032491.0,Moving Averages Indicate These Sector ETFs Could be Stretched,2013-03-25 17:33:00-04:00,PRGO,neutral
1032492.0,UPDATE: Canaccord Genuity Reiterates Perrigo Company at Buy on Launch of Generic Mucinex,2013-03-18 13:34:00-04:00,PRGO,neutral
1032493.0,Perrigo to Begin Shipments of Generic Mucinex 600 mg ER Tablets,2013-03-18 09:02:00-04:00,PRGO,neutral
1032494.0,UBS Upgrades Perrigo Company to Buy,2013-02-25 08:49:00-05:00,PRGO,neutral
1032495.0,Benzinga's Top Upgrades,2013-02-25 07:16:00-05:00,PRGO,positive
1032496.0,A Peek Into The Market Before The Trading Starts,2013-02-25 07:13:00-05:00,PRGO,neutral
1032497.0,Perrigo Confirms First to File Patent Challenge for Generic Version of Testosterone Gel 1.62%,2013-02-19 09:21:00-05:00,PRGO,positive
1032498.0,Top 4 Stocks In The Drug Related Products Industry With The Highest EPS,2013-02-13 01:24:00-05:00,PRGO,positive
1032499.0,UPDATE: Deutsche Bank Raises PT to $115 on Perrigo Post Rosemont Acquisition,2013-02-12 13:49:00-05:00,PRGO,neutral
1032500.0,"Deutsche Bank Maintains Hold on Perrigo Company, Raises PT to $115.00",2013-02-12 07:39:00-05:00,PRGO,neutral
1032501.0,"Goldman Sachs Maintains Sell on Perrigo Company, Raises PT to $112.00",2013-02-11 15:26:00-05:00,PRGO,neutral
1032502.0,"Top Performing Industries For February 11, 2013",2013-02-11 10:53:00-05:00,PRGO,positive
1032503.0,Perrigo Company Sees FY2013 EPS $5.53-5.73 vs $5.56 Est,2013-02-11 08:50:00-05:00,PRGO,neutral
1032504.0,Perrigo Buys Rosemont Pharma for $283M,2013-02-11 08:45:00-05:00,PRGO,neutral
1032505.0,Perrigo Confirms FDA Approval for Generic AbbVie Product,2013-02-05 13:30:00-05:00,PRGO,positive
1032506.0,"UPDATE: Morgan Stanley Upgrades Perrigo Company to Overweight on Outlook, Valuation",2013-02-04 09:04:00-05:00,PRGO,negative
1032507.0,"UPDATE: Canaccord Genuity Upgrades Perrigo Company to Buy on Valuation, Upside Catalysts",2013-02-04 07:32:00-05:00,PRGO,neutral
1032508.0,"Morgan Stanley Upgrades Perrigo Company to Overweight, Raises PT to $125.00",2013-02-04 06:37:00-05:00,PRGO,negative
1032509.0,"Canaccord Genuity Upgrades Perrigo Company to Buy, Raises PT to $128.00",2013-02-04 06:24:00-05:00,PRGO,neutral
1032510.0,Perrigo to Buy Valcera for $160M,2013-02-01 07:48:00-05:00,PRGO,neutral
1032511.0,Perrigo Company Sees FY2013 EPS $4.73-4.93 vs $5.54 Est,2013-02-01 07:47:00-05:00,PRGO,neutral
1032512.0,Perrigo Company Reports Q2 EPS of $1.36 vs $1.33 Est; Revenue of $883.0M vs $886.36M Est,2013-02-01 07:47:00-05:00,PRGO,neutral
1032513.0,"Benzinga Market Primer: Friday, February 1: Non-Farm Payrolls Edition",2013-02-01 06:27:00-05:00,PRGO,neutral
1032514.0,"Earnings Scheduled For February 1, 2013",2013-02-01 04:14:00-05:00,PRGO,neutral
1032515.0,Navigating Volatility During Earnings Season,2013-01-28 10:55:00-05:00,PRGO,neutral
1032516.0,Benzinga's Top Initiations,2013-01-28 07:43:00-05:00,PRGO,positive
1032517.0,Perrigo Launches Store-Brand Version of Nicorette Mini Nicotine Lozenges,2013-01-22 08:36:00-05:00,PRGO,neutral
1032518.0,Perrigo Launches betamethason valerate foam 0.12% Commercially,2013-01-15 12:27:00-05:00,PRGO,neutral
1032519.0,UPDATE: Goldman Sachs Downgrades Perrigo Company to Sell on Slowing Growth  ,2013-01-14 08:51:00-05:00,PRGO,positive
1032520.0,"Goldman Sachs Downgrades Perrigo Company to Sell, Lowers PT to $110.00",2013-01-14 07:42:00-05:00,PRGO,negative
1032521.0,UPDATE: Goldman Sachs Downgrades Perrigo Company to Sell on Slowing Growth  ,2013-01-11 08:56:00-05:00,PRGO,positive
1032522.0,"Goldman Sachs Downgrades Perrigo Company to Sell, Lowers PT to $110.00",2013-01-11 06:50:00-05:00,PRGO,negative
1032523.0,Perrigo Receives FDA Clearance to Manufacture Three Codex-Compliant Infant Formulas,2013-01-07 08:13:00-05:00,PRGO,neutral
1032524.0,"Benzinga's M&A Chatter for Friday December 28, 2012",2012-12-29 16:57:00-05:00,PRGO,neutral
1032525.0,Perrigo Buys Remaining Stake in Cobrek Pharma for ~$45M,2012-12-28 09:27:00-05:00,PRGO,neutral
1032526.0,"Morgan Stanley Maintains Equal-weight on Perrigo Company, Lowers PT to $110.00",2012-11-29 06:59:00-05:00,PRGO,negative
1032527.0,Perrigo Confirms Settlement of Generic Version of Ofirmev(R),2012-11-28 08:45:00-05:00,PRGO,neutral
1032528.0,"Cadence, Perrigo Settle OFIRMEV Injection Patent Litigation",2012-11-28 07:22:00-05:00,PRGO,negative
1032529.0,Perrigo Announces FDA Final Approval Of Betamethasone Valerate Foam 0.12%,2012-11-27 12:43:00-05:00,PRGO,positive
1032530.0,Perrigo Wins FDA Approval of Betamethasone Valerate Foam 0.12%,2012-11-27 12:41:00-05:00,PRGO,positive
1032531.0,Impax Labs Enters Commercialization Deal with Perrigo,2012-11-21 08:02:00-05:00,PRGO,neutral
1032532.0,Perrigo Confirms Settlement Of Generic Version Of Acetadote Injection Patent Litigation,2012-11-13 14:59:00-05:00,PRGO,negative
1032533.0,Caris & Company Downgraded Perrigo from Buy to Above Average,2012-11-08 10:36:00-05:00,PRGO,neutral
1032534.0,Perrigo Raises FY EPS Guidance to $5.45-5.65 vs $5.50 Est,2012-11-07 07:53:00-05:00,PRGO,neutral
1032535.0,Perrigo Reports Q1 EPS $1.27 vs $1.24 Est; Revenues $769.8M vs $825.73M Est,2012-11-07 07:52:00-05:00,PRGO,neutral
1032536.0,US Stock Futures Up After Obama Victory,2012-11-07 05:39:00-05:00,PRGO,neutral
1032537.0,"Earnings Scheduled For November 7, 2012",2012-11-07 02:31:00-05:00,PRGO,neutral
1032538.0,From Earlier: Perrigo Lifts Qtr. Dividend from $0.08 to $0.09/Share,2012-11-06 11:39:00-05:00,PRGO,neutral
1032539.0,UPDATE: Barrington Research Upgrades Perrigo to Outperform Ahead of FQ1 Results  ,2012-11-05 08:43:00-05:00,PRGO,neutral
1032540.0,Barrington Research Upgrades Perrigo from Market Perform to Outperform,2012-11-05 07:32:00-05:00,PRGO,neutral
1032541.0,Perrigo Confirms FDA Tentative Approval For OTC Version Of Omeprazole And Sodium Bicarbonate Capsules,2012-10-16 08:58:00-04:00,PRGO,positive
1032542.0,"UPDATE: J.P. Morgan Reiterates Neutral Rating, Raises PT on Perrigo Company",2012-10-15 11:55:00-04:00,PRGO,neutral
1032543.0,"JP Morgan Maintains Perrigo at Neutral, Raises PT from $102 to $108",2012-10-15 09:42:00-04:00,PRGO,positive
1032544.0,Perrigo Receives FDA Approval To Market Mini Nicotine Lozenges,2012-10-10 08:44:00-04:00,PRGO,positive
1032545.0,Caris Upgrades Perrigo from Above Average to Buy,2012-09-14 08:02:00-04:00,PRGO,neutral
1032546.0,"Deutsche Bank Maintains Perrigo at Hold, Raises PT from $101 to $112",2012-09-14 06:24:00-04:00,PRGO,neutral
1032547.0,"Perrigo Will Buy Assets of Sergeant's Pet Care Products for $285M, Sees Deal Adding $0.20 to EPS in First FY",2012-09-13 07:33:00-04:00,PRGO,positive
1032548.0,Perrigo Confirms First To File Patent Challenge For Generic Version Of ProAir HFA Inhalation Aerosol,2012-09-06 13:20:00-04:00,PRGO,positive
1032549.0,Perrigo and Tris Pharma Launch Store Brand Version of Delsym,2012-08-27 08:39:00-04:00,PRGO,neutral
1032550.0,Top 4 Stocks In The Drug Related Products Industry With The Highest Operating Margin,2012-08-17 04:07:00-04:00,PRGO,positive
1032551.0,Perrigo Guides FY EPS $5.30-5.50 vs $5.43 Est,2012-08-16 07:57:00-04:00,PRGO,neutral
1032552.0,Perrigo Reports Q4 EPS $1.28 vs $1.26 Est; Revenues $831.8M vs $855.80M Est,2012-08-16 07:56:00-04:00,PRGO,neutral
1032553.0,"Earnings Scheduled For August 16, 2012",2012-08-16 04:37:00-04:00,PRGO,neutral
1032554.0,Perrigo Receives FDA Approval And Commences Launch Of Morphine Sulfate 100ml/5% Oral Solution,2012-08-08 09:50:00-04:00,PRGO,positive
1032555.0,"UBS Downgrades Perrigo from Buy to Neutral, Maintains PT at $120",2012-07-20 11:49:00-04:00,PRGO,neutral
1032556.0,"Bank of America Maintains Perrigo at Underperform, Raises PO from $96 to $104",2012-07-20 08:50:00-04:00,PRGO,negative
1032557.0,Benzinga's Top Downgrades,2012-07-20 07:28:00-04:00,PRGO,positive
1032558.0,UPDATE: Canaccord Genuity Downgrades Perrigo Company,2012-07-12 08:36:00-04:00,PRGO,neutral
1032559.0,Benzinga's Top Downgrades,2012-07-12 07:28:00-04:00,PRGO,positive
1032560.0,"Canaccord Genuity Downgrades Perrigo from Buy to Hold, Maintains PT at $125",2012-07-12 06:16:00-04:00,PRGO,neutral
1032561.0,UPDATE: Morgan Stanley Downgrades Perrigo Company to Equal-Weight After Shares Rally,2012-07-06 09:31:00-04:00,PRGO,positive
1032562.0,UPDATE: Morgan Stanley Downgrades Perrigo; Raises PT,2012-07-06 09:22:00-04:00,PRGO,neutral
1032563.0,UPDATE: Goldman Sachs Raises Perrigo's PT,2012-07-06 08:18:00-04:00,PRGO,neutral
1032564.0,"Financial Breakfast: Morning News Summary for July 6, 2012",2012-07-06 07:22:00-04:00,PRGO,neutral
1032565.0,"Morgan Stanley Downgrades Perrigo from Overweight to Equal-Weight, Raises PT from $110 to $125",2012-07-06 06:39:00-04:00,PRGO,negative
1032566.0,Goldman Sachs Raises PT on Perrigo from $100 to $115,2012-07-06 06:26:00-04:00,PRGO,neutral
1032567.0,Perrigo Receives FDA Approval and Commences Launch of Clindamycin Phosphate and Benzoyl Peroxide 1.2% / 5% Gel ,2012-06-27 08:01:00-04:00,PRGO,positive
1032568.0,Top 4 Stocks In The Drug Related Products Industry With The Lowest PEG Ratio,2012-06-13 06:18:00-04:00,PRGO,negative
1032569.0,Perrigo Announces Settlement of Clobetasol Propionate E-Foam 0.05% Patent Litigation ,2012-06-11 08:31:00-04:00,PRGO,negative
1032570.0,Perrigo Receives FDA Approval for Calcium Acetate Capsules,2012-06-06 09:27:00-04:00,PRGO,positive
1032571.0,Perrigo Announces FDA Final Approval Of Tris Pharma's Dextromethorphan Polistirex Extended-Release Oral Suspension ,2012-05-30 12:24:00-04:00,PRGO,positive
1032572.0,Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream,2012-05-22 16:39:00-04:00,PRGO,positive
1032573.0,Perrigo Announces FDA Final Approval and Launch of Store Brand OTC Lansoprazole 15mg Capsules ,2012-05-18 13:33:00-04:00,PRGO,positive
1032574.0,"UPDATE: Stifel Nicolaus Initiates Perrigo Company with Buy, $125 PT; Leading Store Brand Pharma  ",2012-05-15 10:28:00-04:00,PRGO,neutral
1032575.0,"Stifel Nicolaus Initiates Coverage on Perrigo at Buy, Announces PT of $125",2012-05-15 08:08:00-04:00,PRGO,neutral
1032576.0,UPDATE: Deutsche Bank Lowers Perrigo's PT,2012-05-09 07:24:00-04:00,PRGO,negative
1032577.0,"Deutsche Bank Maintains Perrigo at Hold, Lowers PT from $103 to $101",2012-05-09 06:08:00-04:00,PRGO,negative
1032578.0,Perrigo Reports Q3 EPS $1.41 vs $1.22 Est; Revenues $778M vs $828.58M Est,2012-05-08 08:12:00-04:00,PRGO,neutral
1032579.0,Earnings Scheduled For May 8,2012-05-08 00:31:00-04:00,PRGO,neutral
1032580.0,S&P: Bullish On Pharma ETFs Long-Term,2012-04-19 14:45:00-04:00,PRGO,neutral
1032581.0,UPDATE: Deutsche Bank Raises PT to $103 on Perrigo   ,2012-04-16 07:10:00-04:00,PRGO,neutral
1032582.0,"Deutsche Bank Maintains Perrigo at Hold, Raises PT from $100 to $103",2012-04-16 06:43:00-04:00,PRGO,neutral
1032583.0,Perrigo Announces the Launch of Guaifenesin Extended-Release 600mg Tablets,2012-04-12 14:13:00-04:00,PRGO,neutral
1032584.0,Perrigo Announces Australian Approval for Generic Temozolomide ,2012-03-21 14:59:00-04:00,PRGO,positive
1032585.0,"UBS Maintains Perrigo at Buy, Raises PT from $115 to $120",2012-03-05 12:21:00-05:00,PRGO,neutral
1032586.0,"UBS Maintains Perrigo at Buy, Raises PT from $115 to $120",2012-03-05 12:19:00-05:00,PRGO,neutral
1032587.0,"Canaccord Upgrades Perrigo from Hold to Buy, Raises PT to $125",2012-03-05 09:19:00-05:00,PRGO,neutral
1032588.0,Top 4 Stocks In The Drug Related Products Industry With The Highest EPS,2012-03-01 02:56:00-05:00,PRGO,positive
1032589.0,Hearing JP Morgan Making Cautious Comments on Perrigo,2012-02-28 11:00:00-05:00,PRGO,positive
1032590.0,"Morgan Stanley Initiates Coverage on Perrigo at Overweight, Announces PT of $110",2012-02-17 06:03:00-05:00,PRGO,negative
1032591.0,UPDATE: Perrigo Announces the Launch of Loratadine-D 12 Store Brand Labels ,2012-02-14 08:35:00-05:00,PRGO,neutral
1032592.0,Perrigo CEO Papa: 'We Make Our Own Active Ingredients. That Allows Us to Keep Our Cost Basis Down',2012-02-08 18:54:00-05:00,PRGO,positive
1032593.0,Perrigo CEO Papa: 'New Innovations from National Brands Gives Us More Targets to Follow with Our Products',2012-02-08 18:53:00-05:00,PRGO,neutral
1032594.0,Jim Cramer Interviews CEO Joseph C. Papa of Perrigo,2012-02-08 18:51:00-05:00,PRGO,neutral
1032595.0,PREVIEW: Jim Cramer to Interview CEO of Perrigo on Mad Money ,2012-02-08 18:13:00-05:00,PRGO,negative
1032596.0,Collins Stewart Says to Buy Perrigo on Weakness,2012-02-08 11:52:00-05:00,PRGO,negative
1032597.0,JP Morgan Maintains Neutral on Perrigo Company,2012-02-07 10:40:00-05:00,PRGO,positive
1032598.0,Perrigo Up 5% After Beating Earnings Estimates,2012-02-07 09:11:00-05:00,PRGO,negative
1032599.0,Benzinga's Top Pre-Market Gainers,2012-02-07 08:16:00-05:00,PRGO,positive
1032600.0,Perrigo Reports Q2 EPS $1.20 vs $1.16 Est; Revenues $838.2M vs $809.91M Est				 ,2012-02-07 07:53:00-05:00,PRGO,neutral
1032601.0,Notable Put Options Activity in Perrigo,2012-02-03 11:13:00-05:00,PRGO,neutral
1032602.0,Perrigo Confirms Filing for Generic Version of AsteproÂ® Nasal Spray; Patent Infringement Lawsuit by Meda Pharmaceuticals ,2012-01-23 08:50:00-05:00,PRGO,negative
1032603.0,Perrigo Wins Summary Judgment in Generic Mucinex Case ,2012-01-12 08:52:00-05:00,PRGO,positive
1032604.0,"Benzinga's M&A Chatter for Monday January 9, 2012",2012-01-09 18:40:00-05:00,PRGO,neutral
1032605.0,Perrigo Acquires Assets of CanAm Care for $36 Million ,2012-01-09 08:34:00-05:00,PRGO,positive
1032606.0,Notable Put Options Activity on Perrigo,2011-12-28 14:07:00-05:00,PRGO,neutral
1032607.0,Eight Healthcare Stocks Insiders Are Bullish About,2011-12-27 15:04:00-05:00,PRGO,neutral
1032608.0,Will This Company's Drug Cure Your Allergies?,2011-12-27 12:32:00-05:00,PRGO,neutral
1032609.0,Perrigo Announces FDA Final Approval for Desloratadine ,2011-12-27 09:30:00-05:00,PRGO,positive
1032610.0,Perrigo Hits 52-Week High of $102.67,2011-12-22 09:37:00-05:00,PRGO,neutral
1032611.0,Perrigo Hits 52-Week High of $101.95,2011-12-21 14:37:00-05:00,PRGO,neutral
1032612.0,"After Market Close, S&P500 Will Remove AK Steel, Monster Worldwide, MEMC Electronic and Replace with BorgWarner, Perrigo, Dollar Tree",2011-12-16 15:46:00-05:00,PRGO,neutral
1032613.0,"Perrigo, Dollar Tree Will Replace Monster, MEMC in S&P 500",2011-12-08 17:22:00-05:00,PRGO,neutral
1032614.0,Want More Tech ETFs? Global X Has Your Back,2011-12-06 14:58:00-05:00,PRGO,positive
1032615.0,US Stock Futures Up After S&P Euro-Zone Warning,2011-12-06 06:29:00-05:00,PRGO,negative
1032616.0,Stocks To Watch For December 6,2011-12-06 03:41:00-05:00,PRGO,neutral
1032617.0,"Collins Stewart Has Buy, $117 PT On Perrigo",2011-11-28 12:18:00-05:00,PRGO,neutral
1032618.0,Collins Stewart Maintains Buy on Perrigo After FDA Approval for Generic Mucinex Brand,2011-11-28 09:28:00-05:00,PRGO,positive
1032619.0,Perrigo Receives Final FDA Approval for Store Brand Equivalent to Generic Version of Mucinex,2011-11-28 08:05:00-05:00,PRGO,positive
1032620.0,Perrigo Receives FDA Clearance to Market Store Brand Version of GerberÂ® Good StartÂ® Gentle Infant Formula ,2011-11-15 08:33:00-05:00,PRGO,positive
1032621.0,Perrigo Confirms Filing for Testosterone Gel 1.0% and Announcement of Patent Infringement Lawsuit by Abbott ,2011-11-02 08:33:00-04:00,PRGO,negative
1032622.0,Perrigo Announces Launch of Generic Version of Elestat,2011-11-01 09:21:00-04:00,PRGO,neutral
1032623.0,Perrigo Co Reports Q1 EPS $1.10 vs $1.05 Est; Revenues $725.3M vs $750.13M Est			,2011-10-27 07:48:00-04:00,PRGO,neutral
1032624.0,Perrigo Confirms Filing for Generic Version of PATANASEÂ® Nasal Spray and Announcement of Patent Infringement Lawsuit by Alcon Laboratories ,2011-10-18 10:37:00-04:00,PRGO,negative
1032625.0,Deutsche Bank Reports Earnings on Specialty Pharmaceuticals,2011-10-11 09:37:00-04:00,PRGO,neutral
1032626.0,Perrigo Company Confirms FDA Tentative Approval for Clobetasol Propionate Emulsion Foam ,2011-10-06 09:06:00-04:00,PRGO,positive
1032627.0,"UPDATE: Deutsche Bank Initiates Perrigo at Hold, $100 PT",2011-10-03 08:34:00-04:00,PRGO,neutral
1032628.0,"Deutsche Bank Initiates Perrigo at Hold, $100 PT",2011-10-03 06:39:00-04:00,PRGO,neutral
1032629.0,"McDonald's, MasterCard and Five Other Stocks Worth a Look Now",2011-09-29 14:33:00-04:00,PRGO,positive
1032630.0,UBS Raises PT on Perrigo to $115,2011-09-28 10:36:00-04:00,PRGO,neutral
1032631.0,UPDATE: Goldman Sachs Raises PT on Perrigo to $110,2011-09-28 08:40:00-04:00,PRGO,neutral
1032632.0,UPDATE: J.P. Morgan Raises Price Target on Perrigo to $102,2011-09-28 07:47:00-04:00,PRGO,neutral
1032633.0,Goldman Sachs Raises PT on Perrigo to $110,2011-09-28 06:44:00-04:00,PRGO,neutral
1032634.0,JP Morgan Raises PT on Perrigo Company to $102,2011-09-28 06:25:00-04:00,PRGO,positive
1032635.0,"Hearing MYL, PRGO, IPXL Initiated at Hold by Canaccord",2011-09-28 06:11:00-04:00,PRGO,neutral
1032636.0,Jim Cramer Interviews CEO Joseph Papa of Perrigo on Mad Money,2011-09-27 18:16:00-04:00,PRGO,negative
1032637.0,PREVIEW: Jim Cramer Interviewing Perrigo CEO on Mad Money,2011-09-27 18:12:00-04:00,PRGO,negative
1032638.0,Top Performing Industries For August 30,2011-08-30 10:06:00-04:00,PRGO,positive
1032639.0,Perrigo Announces FDA Final Approval for Ketoconazole Foam. 2% ,2011-08-30 08:33:00-04:00,PRGO,positive
1032640.0,UPDATE: JP Morgan Raises PT on Perrigo from $82 to $88,2011-08-17 08:52:00-04:00,PRGO,positive
1032641.0,"News Summary for August 17, 2011",2011-08-17 07:48:00-04:00,PRGO,neutral
1032642.0,JP Morgan Raises PT on Perrigo Company to $88,2011-08-17 07:00:00-04:00,PRGO,positive
1032643.0,Perrigo Sees Opportunity for Lipitor to Go Over the Counter,2011-08-16 10:45:00-04:00,PRGO,positive
1032644.0,Perrigo Announces Planned $350M Private Placement of Notes,2011-08-16 08:11:00-04:00,PRGO,neutral
1032645.0,Perrigo Guides FY2012 EPS $4.50-4.65 vs $4.60 Est,2011-08-16 08:09:00-04:00,PRGO,neutral
1032646.0,Perrigo Reports Q4 EPS $1.02 vs $0.99 Est; Revenues $704.6M vs $706.03M Est					,2011-08-16 08:07:00-04:00,PRGO,neutral
1032647.0,US Stock Futures Down; Wal-Mart Earnings In Focus,2011-08-16 06:11:00-04:00,PRGO,neutral
1032648.0,Earnings Scheduled For August 16,2011-08-16 04:19:00-04:00,PRGO,neutral
1032649.0,Perrigo Earnings Preview,2011-08-15 09:55:00-04:00,PRGO,neutral
1032650.0,Perrigo Receives FDA Approval to Market Coated Cinnamon Nicotine Gum,2011-07-21 09:44:00-04:00,PRGO,positive
1032651.0,Perrigo Provides Update on Acquisition of Paddock Labs ,2011-06-29 08:56:00-04:00,PRGO,neutral
1032652.0,Perrigo Finds Own Brand Of Profits In Generic Drugs,2011-06-17 12:44:00-04:00,PRGO,positive
1032653.0,Perrigo Announces Launch of the Generic Version of Nasacort AQ  ,2011-06-15 09:14:00-04:00,PRGO,neutral
1032654.0,Top Healthcare and Major Drugs stocks to watch- Sector Performance,2011-05-22 14:55:00-04:00,PRGO,positive
1032655.0,Perrigo's Partner Synthon Receives FDA Tentative Approval for Levocetirizine Solution - Generic Equivalent to Xyzal Oral Solution,2011-05-18 08:15:00-04:00,PRGO,positive
1032656.0,GlaxoSmithKline and Isis Pharmaceuticals partnership shouldn't be overlooked as a long-term,2011-05-18 06:29:00-04:00,PRGO,neutral
1032657.0,Perrigo Announces FDA Final Approval for Ranitidine 150 - Generic Equivalent to Zantac 150,2011-05-16 11:28:00-04:00,PRGO,positive
1032658.0,Perrigo Announces Settlement of Cutivate Lotion Litigation ,2011-05-10 11:32:00-04:00,PRGO,negative
1032659.0,"Upgrades Downgrades, Stocks to Watch May 3",2011-05-03 08:52:00-04:00,PRGO,neutral
1032660.0,Perrigo Reports Q3 EPS of $1.07 vs. $0.97 Estimate; Net Sales $691.6M vs. $687.93M Estimate (PRGO),2011-05-03 08:03:00-04:00,PRGO,neutral
1032661.0,Perrigo Announces FDA Final Approval for Minoxidil Foam - Generic Equivalent to Men's Rogaine Foam ,2011-05-02 12:25:00-04:00,PRGO,positive
1032662.0,Perrigo's PBM Infant Formula Unit Wins Appellate Judgment Versus Mead Johnson ,2011-04-21 10:16:00-04:00,PRGO,positive
1032663.0,"Playing The Growth In Private Labels (RAH, THS, PRGO)",2011-04-19 14:28:00-04:00,PRGO,positive
1032664.0,Perrigo Company Hits 52-Week High (PRGO),2011-04-14 12:24:00-04:00,PRGO,neutral
1032665.0,"Perrigo Partner Teva Receives Final OTC Approval for Sales and Distribution of Fexofenadine HCl 60 mg and 180 mg Tablets (PRGO, TEVA)",2011-04-13 14:19:00-04:00,PRGO,positive
1032666.0,"Benzinga's Top Upgrades (GTXI, PRGO, RVBD, ITMN)",2011-04-13 08:24:00-04:00,PRGO,positive
1032667.0,Goldman Sachs Upgrades Perrigo to Neutral,2011-04-13 07:05:00-04:00,PRGO,neutral
1032668.0,Perrigo Announces Conclusion of the FDA Re-Inspection ,2011-04-12 12:01:00-04:00,PRGO,neutral
1032669.0,"Top Performing Industries For April 11 (BBY, PRGO, GLBC, BCS)",2011-04-11 10:08:00-04:00,PRGO,positive
1032670.0,Perrigo Announces Arrival of the FDA for Reinspection Related to the Allegan Facility Warning Letter ,2011-03-01 09:31:00-05:00,PRGO,negative
1032671.0,"Perrigo Co. Vice-President Sells 4,000 Shares of PRGO",2011-02-18 16:08:00-05:00,PRGO,positive
1032672.0,"Perrigo Co. Director Sells 287,651 Shares of PRGO",2011-02-18 15:58:00-05:00,PRGO,positive
1032673.0,Perrigo Enters Into Exclusive Sales and Distribution Agreement With AgaMatrix ,2011-02-17 08:18:00-05:00,PRGO,positive
1032674.0,Perrigo Announces Settlement of Rogaine Foam Patent Litigation,2011-02-10 08:32:00-05:00,PRGO,negative
1032675.0,Goldman Sachs Morning Summary,2011-02-02 09:42:00-05:00,PRGO,neutral
1032676.0,"Goldman Sachs Raises Perrigo PT To $56, Reiterates Sell (PRGO)",2011-02-02 08:33:00-05:00,PRGO,neutral
1032677.0,Perrigo Reports Q2 EPS of $1.05 vs. $.95,2011-02-01 07:56:00-05:00,PRGO,neutral
1032678.0,Perrigo Company (PRGO) - Bull of the Day,2011-02-01 02:01:00-05:00,PRGO,neutral
1032679.0,Perrigo Company (PRGO) - Bull of the Day,2011-02-01 00:00:00-05:00,PRGO,neutral
1032680.0,"Benzinga's Top Pre-Market NASDAQ Losers (SVNT, PTNR, CIEN, PRGO)",2011-01-31 08:29:00-05:00,PRGO,negative
1032681.0,Perrigo Company Announces Dividend of $.07 ,2011-01-26 10:17:00-05:00,PRGO,neutral
1032682.0,Perrigo to Acquire Paddock's Assets - Analyst Blog,2011-01-24 09:01:00-05:00,PRGO,positive
1032683.0,"Benzinga's Top Downgrades (TSN, PRGO, MIPS, BBW)",2011-01-24 08:32:00-05:00,PRGO,positive
1032684.0,Perrigo to Acquire Paddock's Assets - Analyst Blog,2011-01-24 08:30:00-05:00,PRGO,positive
1032685.0,"Benzinga's Volume Movers (PRGO, SHLD, PZZA, RUSHA)",2011-01-20 11:05:00-05:00,PRGO,neutral
1032686.0,"Top Performing Industries For January 20 (PRGO, LOW, RJF, HIBB)",2011-01-20 10:26:00-05:00,PRGO,negative
1032687.0,Perrigo to Acquire Assets of Paddock Labs for $540M,2011-01-20 07:25:00-05:00,PRGO,positive
1032688.0,3 Breakout Plays To Watch Today,2010-12-20 12:03:00-05:00,PRGO,positive
1032689.0,SPX Stuck with 1245 Resistance in Place 12-17-2010,2010-12-17 17:54:00-05:00,PRGO,negative
1032690.0,"Mad Money Lightning Round OT: Cramer Is A Seller Of KERX (CELG, KERX, PRGO, JNJ, RBY, AEM)",2010-11-30 19:48:00-05:00,PRGO,negative
1032691.0,Perrigo and Synthon Announce FDA Final Approval of Generic Xyzal,2010-11-29 09:43:00-05:00,PRGO,positive
1032692.0,Perrigo Announces Launches Generic Equivalent to Aleve Liquid Gels,2010-11-29 08:46:00-05:00,PRGO,neutral
1032693.0,"Top Narrow Based Indexes For November 22 (PRGO, GMCR, VIT)",2010-11-22 11:20:00-05:00,PRGO,positive
1032694.0,Perrigo Reports Record Earnings of $.87 per Share; Raises FY Guidance,2010-11-02 08:19:00-04:00,PRGO,positive
1032695.0,Perrigo Company Announces Dividend Increase to 7 Cents,2010-10-27 09:44:00-04:00,PRGO,positive
1032696.0,"Benzinga's Top ETF Gainers (SGG, DAG, XPH, FAS)",2010-10-12 18:05:00-04:00,PRGO,positive
1032697.0,"Perrigo Ready to Go, Go, Go (PRGO)",2010-09-24 10:15:00-04:00,PRGO,positive
1032698.0,Perrigo Confirms Filing for Omeprazole/Sodium Bicarbonate and Announcement of Patent Infringement Lawsuit ,2010-09-24 08:23:00-04:00,PRGO,negative
1032699.0,Perrigo Announces FDA Approval,2010-09-08 07:47:00-04:00,PRGO,positive
1032700.0,"Goldman Sachsâ Specialty Pharma Playlist (MYL, AGN, PRGO)",2010-08-31 10:20:00-04:00,PRGO,neutral
1032701.0,"Benzingaâs Volume Movers (CAGC, PRGO, ACLI, SOLF)",2010-08-12 14:05:00-04:00,PRGO,neutral
1032702.0,Perrigo Rising On Heavy Volume (PRGO) ,2010-08-12 10:56:00-04:00,PRGO,neutral
1032703.0,A Peek Into The Market Before The Trading Starts,2010-08-12 09:22:00-04:00,PRGO,neutral
1032704.0,"Benzingaâs Top Pre-Market NASDAQ Gainers (YONG, AVGO, EBAY, PRGO)",2010-08-12 08:48:00-04:00,PRGO,positive
1032705.0,Perrigo Q4 Results Surpass Expectations,2010-08-12 08:16:00-04:00,PRGO,neutral
1032706.0,"Top 4 Stocks In The Drug Related Products With The Highest Free Cash Flow (HLF, NTY, PRGO, SLXP)",2010-07-29 05:48:00-04:00,PRGO,positive
1032707.0,Calls Purchased on Perrigo (PRGO),2010-07-19 11:08:00-04:00,PRGO,neutral
1032708.0,"Goldman Downgrades Perrigo To Sell (GS, PRGO)",2010-07-19 09:56:00-04:00,PRGO,neutral
1032709.0,PRGO Has Unfavorable Risk/Reward Ratio Ahead Of FQ4,2010-07-19 09:47:00-04:00,PRGO,neutral
1032710.0,"Benzingaâs Top Downgrades (FFIV, ADCT, PRGO, FHN)",2010-07-19 09:22:00-04:00,PRGO,positive
1032711.0,"Benzingaâs Top Pre-Market NASDAQ Losers (PRGO, BIDU, TEVA, AAPL)",2010-07-19 09:04:00-04:00,PRGO,negative
1032712.0,Protection Sold on Perrigo (PRGO),2010-06-30 10:28:00-04:00,PRGO,neutral
1032713.0,Perrigo Set To Grow Further (PRGO),2010-05-15 02:39:00-04:00,PRGO,neutral
1032714.0,Johnson & Johnson (JNJ) Woes Benefit Perrigo (PRGO),2010-05-03 09:36:00-04:00,PRGO,neutral
1032715.0,Mad Money Lightning Round: Jim Believes RIMM Is Done,2010-04-27 06:50:00-04:00,PRGO,negative
1032716.0,Volume Talks Wednesday: A Bullish Biotech Breakout Option Play,2010-03-25 09:02:00-04:00,PRGO,positive
1032717.0,"Top Performing Industries For March 23 (PRGO, ESYS, BUCY, CLF, GGOX.OB)",2010-03-23 15:39:00-04:00,PRGO,positive
1032718.0,"Benzingaâs Volume Movers (AGAM, CTEL, PRGO, GIVN, LOPE)",2010-03-23 15:29:00-04:00,PRGO,neutral
1032719.0,Perrigo Company (PRGO) To Acquire PBM Holdings Inc. For $808 Million,2010-03-23 08:31:00-04:00,PRGO,neutral
1032720.0,"Benzingaâs News Roundup (PRGO, AOS, WAG, SKS)",2010-03-23 08:06:00-04:00,PRGO,negative
1032721.0,How Will Obama-Care Play Into The Markets And ETFs?,2010-03-21 21:50:00-04:00,PRGO,positive
1032722.0,"Cramer On Mad Money Recommends JCG, MW, GNTX, DMA; Asks Investors To Avoid CRZO, CLNE",2010-03-08 07:32:00-05:00,PRGO,negative
1032723.0,Thursday's Hot Stocks on Heavier Volume,2010-02-26 10:14:00-05:00,PRGO,neutral
1032724.0,"Benzinga's Unusual Volume (WBMD, ISRG, PRGO)",2010-02-19 10:56:00-05:00,PRGO,neutral
1032725.0,"Benzinga's Top ETF Decliners (DTO, XPH, SCO, UNG)",2010-02-18 15:14:00-05:00,PRGO,positive
1032726.0,Stocks With Excellent Charts,2010-02-17 14:45:00-05:00,PRGO,positive
1032727.0,Perrigo Company (PRGO) Price Target Raised,2010-02-03 15:08:00-05:00,PRGO,neutral
1032728.0,"Benzingaâs Top Pre-Market Losers (AMSC, MPEL, TRGL, PRGO, TUES, LEAP)",2010-02-02 08:54:00-05:00,PRGO,negative
1032729.0,"NASDAQ Pre-Market Top Losers (SQNM, YONG, EZCH, PRGO, ERIC)",2009-12-17 08:55:00-05:00,PRGO,negative
1032730.0,"Benzingaâs Top Pre- Market Losers (C, PRGO, YONG, SQNM, EZCH, CYTX)",2009-12-17 08:48:00-05:00,PRGO,negative
1032731.0,"New 52-Week High Stocks (RCKY, TTEC, UFS, PRGO, PLX)",2009-11-02 11:33:00-05:00,PRGO,neutral
1032732.0,Perrigo (PRGO) Acquires ANDA for Generic Version Duac Gel from KV Pharmaceutical,2009-09-21 12:57:00-04:00,PRGO,neutral
